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Transforming growth factor-β (TGF-β) signaling pathways play a crucial role in cell 
proliferation, migration, and apoptosis through the activation of Smad proteins. Research has 
shown that the biological effects of TGF-β signaling pathway are highly cellular-context-
dependent. In this thesis work, I aimed at understanding how TGF-β signaling can regulate 
target genes differently, how different dynamics of gene expressions are induced by TGF-β 
signal, and what is the role of Smad proteins in differing the profiles of target gene expression.  
In this study, I focused on the transcriptional responses to the Nodal/Activin ligand, which 
is a member of the TGF-β superfamily and a key regulator of early embryonic development. 
Kinetic models were developed and calibrated with the time course data of RNA polymerase 
II (Pol II) and Smad2 chromatin binding profiles for the target genes. Using the Akaike 
information criterion (AIC) to evaluate different kinetic models, we discovered that 
Nodal/Activin signaling regulates target genes via different mechanisms. In the Nodal/Activin-
Smad2 signaling pathway, Smad2 plays different regulatory roles on different target genes. We 
show how Smad2 participates in regulating the transcription or degradation rate of each target 
gene separately. Moreover, a series of features that can predict the transcription dynamics of 
target genes are selected by logistic regression.  
The approach we present here provides quantitative relationships between transcription 
factor dynamics and transcriptional responses. This work also provides a general computational 





Die Signalwege des transformierenden Wachstumsfaktors β (TGF-β) spielen eine 
entscheidende Rolle bei der Zellproliferation, -migration und -apoptose durch die Aktivierung 
von Smad-Proteinen. Untersuchungen haben gezeigt, dass die biologischen Wirkungen des 
TGF-β-Signalwegs stark vom Zellkontext abhängen. In dieser Arbeit ging es darum zu 
verstehen, wie TGF-β-Signale Zielgene unterschiedlich regulieren können, wie 
unterschiedliche Dynamiken der Genexpression durch TGF-β-Signale induziert werden und 
auf welche Weise Smad-Proteine zu unterschiedlichen Expressionsmustern von TGF- β-
Zielgenen beitragen. 
Der Fokus dieser Studie liegt auf den transkriptionsregulatorischen Effekten des Nodal / 
Activin-Liganden, der zur TGF-β-Superfamilie gehört und ein wichtiger Faktor in der frühen 
embryonalen Entwicklung ist. Um diese Effekte zu analysieren, habe ich kinetische Modelle 
entwickelt und mit den Zeitverlaufsdaten von RNA-Polymerase II (Pol II) und Smad2-
Chromatin-Bindungsprofilen für die Zielgene kalibriert. Unter Verwendung des Akaike-
Informationskriteriums (AIC) zur Bewertung verschiedener kinetischer Modelle stellten wir 
fest, dass der Nodal / Activin-Signalweg Zielgene über verschiedene Mechanismen reguliert. 
Im Nodal / Activin-Smad2-Signalweg spielt Smad2 für verschiedene Zielgene unterschiedliche 
regulatorische Rollen. Wir zeigen, wie Smad2 daran beteiligt ist, die Transkriptions- oder 
Abbaurate jedes Zielgens separat zu regulieren. Darüber hinaus werden eine Reihe von 
Merkmalen, die die Transkriptionsdynamik von Zielgenen vorhersagen können, durch 
logistische Regression ausgewählt. 
Der hier vorgestellte Ansatz liefert quantitative Beziehungen zwischen der Dynamik des 
Transkriptionsfaktors und den Transkriptionsantworten. Diese Arbeit bietet auch einen 
allgemeinen mathematischen Rahmen für die Untersuchung der Transkriptionsregulation 
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In this chapter, I will introduce the background of biology and bioinformatics that are related 
to this thesis work. The chapter starts with some introduction of transcriptional regulation and 
TGF-β signaling, followed by a brief review on transcriptome studies, and a detailed 
explanation of high-throughput sequencing techniques. A brief description of the RNA-seq and 
ChIP-seq associated with high-throughput sequencing are given. Finally, an overview on 
computational modeling of transcription dynamics is provided. 
1.2 Transcriptional regulation 
1.2.1 The central dogma of molecular biology 
 Cell is recognized as the basic unit of life. Molecular biology studies the composition, 
structure and interactions of cellular molecules, including proteins and nucleic acids, that are 
important for the functions and maintenance of the cell (Alberts 2017). Deoxyribonucleic acid 
(DNA) is the genetic material of eukaryotic cells. It contains all the information pertaining to 
cellular activities. DNA strands are composed of four simple building blocks called nucleotides. 
The nucleotides are composed of a sugar called deoxyribose, a 5’ phosphate group and one of 
four nucleobase: adenine (A), thymine (T), cytosine (C) and guanine (G). When forming a 
double strand, each nucleotide is connected to a specific partner premised on base-pairing rules 
(A to T and C to G). After discovering the double helical structure of DNA in 1953 (Watson 
and Crick 1953), Francis Crick published the first statement of the central dogma in 1958 
(Crick 1958) and restated in a nature paper titled “central dogma of molecular biology” in 1970 
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(Crick 1970). The central dogma describes the flow between DNA, ribonucleic acid (RNA) 
and proteins (Figure 1).  
 
Figure 1 | Central dogma of molecular biology envisioned. This figure was modified from 
(Krebs, Goldstein et al. 2018).  
The central dogma of molecular biology contains the four main processes of biological systems: 
1)  DNA is copied to produce two identical replicates in a process called replication, 
which is the primary stage in cell information maintains.  
2) Transcription of DNA to RNA is the first step for gene expression. This RNA is a   
complementary and antiparallel copy of the original DNA. 
3) RNA is translated via ribosomes into proteins. Following, the proteins perform their 
functions in further processes. 
4) Reverse transcription uses RNA as a template to synthesis DNA. This process 
involves reverse transcriptase. 
Some parts of the central dogma may not be entirely accurate, for instance, many viruses 
replicate their RNA genomes and transcribe RNA into messenger RNA (mRNA) (Ahlquist 
2002). The central dogma shows the two key steps of gene expression – transcription and 
translation. Many kinds of RNA join these two steps. For example, the ribosomal RNA (rRNA) 
is located in the cytoplasm. It along with proteins forms ribosome that translates mRNA into 
proteins. Transfer RNA (tRNA), which links the amino acids and the mRNA based on three-
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nucleotide codon of rRNA, is also involved in the synthesis of proteins. Additionally, long non-
coding RNAs (lncRNA) perform significant functions in transcription regulation (Geisler and 
Coller 2013). Small interfering RNA (siRNA) and microRNA (miRNA) can mediate gene 
silencing (Kim, Villeneuve et al. 2006, Fabian, Sonenberg et al. 2010). Among these RNAs, 
mRNA - the connector between DNA and protein - is pivotal to the transformation of gene 
information.  
1.2.2 Eukaryotic RNA production 
DNA fragment that includes information about cellular functions - gene - is converted to 
RNA molecule - transcript - by transcription. Opening the chromatin controls the initiation 
level of transcription because eukaryotic genomes are tightly condensed into a chromatin 
structure. Chromatin remodeling decides whether a gene is expressed. It is principally carried 
out by two class coactivators, one of which is the ATP-dependent chromatin-remodeling 
complexes (Becker and Horz 2002) while the other is the histone-modifying complexes, which 
covalent histone modifications (Nakajima, Uchida et al. 1997). The acetylation of histone is a 
characteristic of the activation of gene expression, while the methylation of histone is 
associated with inactive chromatin. 
Transcription begins when one or more basal transcription factors (TFs) bind to the DNA 
with RNA polymerase II (Pol II) at the promoter region of the gene. Then, the DNA is unwound 
to expose the single-strand which syntheses an initial RNA product. This step is called initiation. 
The following step is elongation. During this step, Pol II moves along the DNA to extend the 
RNA copy. In the termination step, both the nascent RNA and Pol II are released from the 





Figure 2 | Gene transcription is coordinated with Pol II CTD phosphorylation. Figure 
modified from (Kuehner, Pearson et al. 2011).  
Gene transcription is mediated by Pol II, whose carboxy-terminal domain (CTD) 
phosphorylation status is associated with the production steps (Figure 2). Pol II CTD contains 
a repeat amino acid consensus sequence (Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7). It is 
phosphorylated by the transcription initiation factor II H (TFIIH) on Ser5 during initiation 
(Holstege, Fiedler et al. 1997). The phosphorylation of Ser2 by the positive transcription 
elongation factor (P-TEFb) activates the elongation process (Price 2000). Though the Pol II 
CTD can be phosphorylated by an unknown kinase on Ser7, its function is not clear yet. 
In general, Ser5 phosphorylation is enriched at the 5’ end of genes and associated with early 
transcription events (Komarnitsky, Cho et al. 2000). In contrast, Ser2 phosphorylation is 
enriched at the 3’ end of genes and involved in 3' end processing (Ahn, Kim et al. 2004). The 
serine phosphorylation is regulated by many kinases such as the suppressor of Sua72 (Ssu72) 
and Fcp1, which can dephosphorylate Ser5 and Ser2 (Werner-Allen, Lee et al. 2011, Fuda, 
Buckley et al. 2012).  
1.2.3 Post-transcriptional modification 
 Post-transcriptional modification, which is also called co-transcriptional modification, is a 
set of biological processes that modify an RNA primary transcript to produce a mature, 
functional RNA molecule after transcription (Kiss 2001). The nascent mRNA is altered in the 
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nucleus through three main processes: 5' capping, 3' polyadenylation and RNA splicing, which 
are described as below (Figure 3). 
1) 5' capping. A cap is formed by adding 7-methylguanosine (m7G) to the 5' end. This 
methylated cap is recognized by the cell’s translational machinery (e.g. nuclear export 
proteins and ribosome) and can affect mRNA splicing, export, translation and stability 
(Jacobson and Peltz 1996). 
2) 3' polyadenylation. The sequence AAUAAA provides the signal for cleavage and for 
receiving a poly(A) tail at the 3’ end. The major functions of the poly(A) tail are to 
protect the mRNA from degradation and facilitate exportation of mRNA from the 
nucleus (Drummond, Armstrong et al. 1985).  
3) RNA splicing. Splicing occurs through breaking exon-intron junctions and joining 
exons’ end. The sequence that is removed by splicing during mature mRNA forming is 
called intron. However, splicing can also result in different mRNA products when 
alternative splicing junctions are used. This is known as alternative splicing. Alternative 
splicing allows structural and functional variation of gene products. Following splicing, 
nascent mRNA becomes mature and functional. It will be transported from the nucleus 









Figure 3 | Post-transcriptional modification and alternative splicing. (A) RNA is modified 
by adding m7G and poly(A) tail to the 5’ and  3’ ends in the nucleus. The introns are removed 
by splicing. (B) Different combinations of exons from a single pre-mRNA cause various 
mRNAs to be translated into different proteins. Thus, a single gene can encode multiple 
proteins. 
1.2.4 Eukaryotic mRNA degradation  
Most eukaryotic mRNA degradation is initiated as poly(A) tails are shorten by a poly(A) 
nuclease until it reaches a length of around 10A (Krebs, Goldstein et al. 2018). Then, the 
mRNA may be degraded either by the 5’ to 3’ pathway, or by the 3’ to 5’ pathway. The 5’ to 
3’ pathway involves Dcp1/2 for decapping and Xrn1 for 5’ to 3’ exonuclease digestion. The 3’ 
to 5’ pathway involves the exosome complex for digestion. There are four other pathways for 
mRNA degradation in eukaryotic cells: deadenylation-independent decapping pathway, 
endonucleolytic pathway, histone mRNA pathway and miRNA pathway. Degradation of some 
specific mRNAs may be initiated by decapping. Few specific mRNAs can be cut by 
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endonuclease cleavage before 5’ to 3’ and 3’ to 5’ exonuclease digestion. Histone mRNA in 
mammals receive a short poly(U) tail before normal degradation. MicroRNA is able to target 
some RNA for silencing or degradation. Due to different degradation pathways, mRNAs 
exhibit a wide range of stabilities that contribute to differential mRNA abundance in a cell. 
Therefore, the spectrum of proteins made in a cell is also related to the stability of mRNAs. 
1.2.5 Eukaryotic transcription regulation 
Although the regulation of RNA processing may be taken in many steps during gene 
expression, eukaryotic gene expression is mainly controlled at the initiation level of 
transcription (Lemon and Tjian 2000, White 2009). Transcription initiation can be regulated 
by multiple proteins that bind to specific regulatory sequences and modulate Pol II activity. 
Different transcriptional regulatory proteins contribute to the regulation of various gene 
expressions in the different cell types. Moreover, chromatin remodeling and histone 
modification in the modification of chromatin structure also influence eukaryotic gene 
expression. In the following section, I will elaborate these transcriptional regulations. 
1.2.5.1 Cis-regulatory modules 
Cis-regulatory module (CRM) is a 100-1000 base pairs (bp) DNA that regulates 
transcription rates of target genes and their expressions by binding numerous TFs,  such as 
enhancers, promoters, silencers, boundary elements and locus control regions (Davidson 2006, 
Jeziorska, Jordan et al. 2009) (Figure 4). Among these CRMs, the promoter leads to the 
initiation of transcription of a particular gene with the aid of the pre-initiation complex. 
Commonly, promoters are located upstream of the transcription start sites (TSS) of genes. 
Promoters lack universal structural features, while two functional parts are always present 
(Juven-Gershon and Kadonaga 2010). One functional part is the basal promoter (or core 
promoter) situated at about -35 bp to the TSS. The basal promoter provides a binding site for 
the transcription complex and localizes the transcription initiation site relative to the coding 
sequences (Reinberg, Orphanides et al. 1998, Lee and Young 2000). For many genes, it 
contains a TATA box, to which the TATA-binding protein (TBP) binds (Lifton, Goldberg et 
al. 1978). The other functional part of promoters is the binding site for a specific TF at 
approximately 250 bp or further upstream from the TSS. The TFs are necessary to activate or 
repress genes under various conditions (Lemon and Tjian 2000).  Another CRM that regulates 
transcription is the enhancer. It can be located at a great distance (sometimes more than 10 
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kilobases) upstream or downstream from the TSS of regulated genes. Like promoters, the 
enhancers also function by binding TFs. Enhancer-bound TF can interact with the proteins at 
the promoter through DNA looping (Cooper, Hausman et al. 2000), 
 
Figure 4 | Organization of a generalized eukaryotic gene. The transcription units, basal 
promoter and specific transcription factor binding sites are shown above. Figure modified from 
(Wray, Hahn et al. 2003). 
1.2.5.2 Transcription factors 
 Transcription factors are proteins that bind to the specific DNA sequences and regulate the 
transcription rate of target genes (Figure 5). Basal factors, activators and coactivators are 
different types of transcription factors. The basal factors bind the start point in the promoter to 
the RNA polymerase. Activators work by making protein-protein interactions with the basal 
apparatus at the promoters or enhancers. Coactivators are needed by some activators to mediate 
the interaction. Activators control the frequency of transcription to make sure that genes are 
expressed correctly depending on the requirements of cellular environments. In human, 
Vaquerizas et al. estimated that roughly 6% of the expressed genes are TFs and the number of 
TFs expressed in each tissue is between 150 and 300 (Vaquerizas, Kummerfeld et al. 2009). 
Although only an average 6% of protein-coding genes in a tissue are TFs, they are still able to 
play different roles in regulating different genes as they are able to affect the transcription of 




Figure 5 | Eukaryotic transcription factors. Several TATA-binding protein (TBP)-
associated factors (TAFs, also known as general transcription factors) bind the basal promoter 
with RNA polymerase II holoenzyme complex and TBP. Transcription factors interact with 
transcription cofactors and chromatin remodeling complexes at the regulatory regions. Figure 
modified from (Wray, Hahn et al. 2003). 
1.2.5.3 Chromatin structure  
 The DNA of all eukaryotic cells is compacted with the help of chromatin proteins such as 
histones H2A, H2B, H3, and H4. These positively charged proteins form complexes called 
nucleosomes by binding to negatively charged DNA. Nucleosomes can pack into a 30-nm 
chromatin fiber, which forms loops with a length of about 300 nm. The 300 nm fibers are 
further compressed and coiled into the chromatid of a chromosome (Pierce 2012). This packing 
of eukaryotic DNA has an important impact on gene expression. The general process of the 
dynamic modification of chromatin architecture is called chromatin remodeling. There are two 
major chromatin-remodeling complexes: covalent histone-modifying complexes and ATP-
dependent chromatin remodeling complexes (Teif and Rippe 2009). When remodeling is 
carried out by covalent histone-modifying complexes, the modifications of histones match well 
with gene expression states. Histone acetylation is linked to transcription activation and 
deacetylation is linked to the repression of gene activity. However, the methylation of histones 
correlates with both active and inactive regions. The methylation of DNA is another feature 
linked to the chromatin structure and is a feature of inactive chromatin. 
mRNAs are unstable molecules and are regulated in a number of different ways. Cells can 
respond to signals from their environment through changing gene expression and protein 
activity, both of which play crucial roles in regulating mRNAs. Understanding the interplay 
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between cell signaling and transcriptional regulation is an active area of research that remains 
to be explored and investigated. 
1.3 The TGF-β and Nodal/Activin signaling pathways 
1.3.1 The TGF-β superfamily 
The transforming growth factor-β (TGF-β) superfamily plays a crucial role in controlling 
cell proliferation, migration, and apoptosis through the regulation of gene expressions (Wu and 
Hill 2009). In the early 1980s, the TGF-β family was isolated from many non-neoplastic tissues 
of the adult mouse and was discovered to induce a transformed phenotype in non-neoplastic 
cultured cells (Roberts, Anzano et al. 1981). Since then, several other TGF-β superfamily 
proteins have been identified, bringing the number up to more than 33 members, including 
TGF-βs themselves, bone morphogenetic proteins (BMPs), growth and differentiation factors 
(GDFs), Activins, and Nodal (Feng and Derynck 2005) (Figure 6). The TGF-β superfamily 
proteins are distinct, but they have similar structures and their regulated downstream 









Figure 6 | The 33 TGF-β family polypeptides in human. Ligands that signal through R-
Smads activated by Activin or TGF-β or R-Smads activated by BMP are shown in red or blue, 
respectively. Ligands that may signal through these two types of R-Smads, but whose receptors 
and pathways have not been fully identified, are shown in orange or light blue, respectively. 
BMP, Bone morphogenetic protein; OP, osteogenic protein; GDF, growth and differentiation 
factor; CDMP, cartilage-derived morphogenetic protein; MIS/AMH, Müllerian-inhibiting 
substance/anti-Müllerian hormone; TGF-β, transforming growth factor β.  Figure modified 
from (Morikawa, Derynck et al. 2016). 
The synthesis, secretion, and activation of polypeptides from the TGF-β superfamily consist 
of multiple complex processes and they are controlled by several proteins (Figure 7). TGF-β 
ligands are initially synthesized as pre-propeptides, which are called pre-pro-TGF-β. Then, the 
N-terminal signal peptide (SP) of the pre-pro-TGF-β is removed to produce a dimeric mature 
peptide (Derynck, Jarrett et al. 1985, Gentry and Nash 1990). After it is synthesized, the pro-
TGF-β, which contains the C-terminal mature TGF-band and the N-terminal pro-domain TGF-
β latency associated protein (LAP), is cleaved by the cleaving enzyme (furin, PACE) from its 
propeptide (Dubois, Blanchette et al. 2001, Kusakabe, Cheong et al. 2008). That creates a small 
latent TGF-β complex (SLC) which is connected with the latent TGF-β-binding proteins 
(LTBPs) to form the large latent complex (LLC) (Saharinen, Taipale et al. 1996). In the next 
step, the LLC is secreted from a cell and then processed to release active TGF-β (Annes, 
Munger et al. 2003). The key difference for distinguishing TGF-β superfamily members is the 
number and location of the cysteines. For example, three TGF-β isoforms contain nine 
cysteines while all other TGF-β superfamily members contain either seven or five cysteines 




Figure 7 | A schematic representation of the different forms of TGF-β which occur during 
synthesis, secretion, and activation. Figure modified from (Poniatowski, Wojdasiewicz et al. 
2015). 
The biological effects of TGF-β superfamily are highly cellular-context dependent. For 
example, TGF-β1 enhances the endometrial decidualization (Kim, Park et al. 2005) and is 
related to embryo implantation (Manova, Paynton et al. 1992). BMPs are key players in the 
regulation of cell fate choices in developmental contexts (Bier and De Robertis 2015). These 
lead to a diversity cellular response during embryonic development. 
1.3.2 TGF-β receptors 
TGF-βs transduce their signals through a serine/threonine transmembrane receptor complex, 
forming a heterotetrameric combination. The receptors, which are known as TGF-β type I 
(T𝛽𝛽RI, TGFBR1) and type II (T𝛽𝛽RII, TGFBR2) receptors, have similar structures (Greenwald, 
Fischer et al. 1999). They can be distinguished from one another by peptide mapping. These 
receptors can be further categorized as seven T𝛽𝛽RI, termed the Activin-like receptors (ALK1–
7) and five T𝛽𝛽RII receptors, termed TGFβR2, BMPR2, ACVR2A, ACVR2B and AMHR2 
(Wrana, Attisano et al. 1992). Other than T𝛽𝛽RI and TGFBR2, a type III (T𝛽𝛽RIII, TGFBR3, 
betaglycan) receptor was also determined. It acts as a reservoir of ligand for TGF-beta receptors 
but lacks the domain for serine/threonine activity (Andres, Stanley et al. 1989). 
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Upon activation, T𝛽𝛽RII is autophosphorylated in serine and threonine residues after binding 
with TGF-β (Wrana, Attisano et al. 1992). Then, it recruits T𝛽𝛽RI and phosphorylates the serine 
and glycine rich domain (GS domain) of the T𝛽𝛽RI. Two T𝛽𝛽RI subunits and two T𝛽𝛽RII subunits 
form a complex consisting of a TGF-β ligand and a receptor heterotetramer. Phosphorylation 
allows T𝛽𝛽RI to propagate the signal to downstream substrates (Wrana, Attisano et al. 1994). 
Activated T𝛽𝛽RI regulates the intracellular signaling by phosphorylating receptor-regulated 
Smads (R-Smads). 
1.3.3 Smad proteins and canonical TGF-β signaling 
The diverse effects of the TGF-β superfamily are mainly mediated through the so-called 
"mothers against decapentaplegic" or Smad proteins. The Smad family is conserved and has 
eight Smads members that can be classified into three categories (Huminiecki, Goldovsky et 
al. 2009) (Figure 8):  
1) Receptor-activated Smads (R-Smads, Smad1, 2, 3, 5 and 8), which are regulated by 
T𝛽𝛽RI and can be further separated into two subcategories:  
a. Smad2 and 3, which are phosphorylated by ALK4, 5, and 7. They are 
downstream of TGF-β and Activin signals. 
b. Smad1, 5 and 8, which are phosphorylated by ALK1, 2, 3, and 6. They are 
transduced by BMPs. 
2) Common mediator Smads (Co-Smads, Smad4), which form heteromeric complexes 
with R-Smads to recruit co-regulators. 
3) Inhibitory Smads (I-Smads, Smad6 and 7), which inhibit the activation of R-Smads.  
R-Smads and Co-Smads have conserved Mad-homology 1 (MH1) and MH2 domains at 
their N-termini and C-termini, which are connected by a linker (Massague 1998). On the other 
hand, I-Smads only have conserved MH2 domains but lack MH1 domains, which are 
fundamental for DNA binding (Huminiecki, Goldovsky et al. 2009). MH1 region contains β-
hairpin (βH) domain to mediate specific DNA binding of Smad3 and 4 (Shi, Wang et al. 1998). 
MH2 regions play crucial roles in the Smad–Smad protein interactions and transcriptional 
activations. The C-terminus SxS motif in MH2 of R-Smads is the target of T𝛽𝛽RI (Abdollah, 
Macias-Silva et al. 1997, Feng and Derynck 2005). The L3 loop within MH2 domain indicates 
specificity in T𝛽𝛽RI interaction (Lo, Chen et al. 1998). The Smad4 activation domain (SAD), 
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instead of PPXY motif in Smad4, is essential for mediating activation of Smads complex (De 
Caestecker, Yahata et al. 2000). 
 
Figure 8 | The Smad family. Left-hand shows the phylogenetic tree of vertebrate Smads 
(except for Xenopus Smad4b [XSmad4b]). The schematic structure/function diagram 
illustrates receptor-activated Smads (R-Smad) (here is an example of Smad2, 3), the common-
partner Smads (Co-Smad) (example shown here Smad4) and inhibitory Smads (I- Smads) 
(example here Smad7). βH, the β-hairpin domain. PPXY, the proline-tyrosine motif. L3, the 
L3 loop. SxS, the C-terminus SxS motif. SAD, the Smad4 activation domain. Triangles (Smad2) 
indicate extra exons in Smad2 compared with Smad3. This figure is modified from (Schiffer, 
von Gersdorff et al. 2000). 
 After phosphorylation of the C-terminal serines by T𝛽𝛽RI, R-Smads are activated, then 
form complexes with a Co-Smad and translocate into the nucleus where they recruit sequence-
specific TFs to regulate gene transcriptions (Miyazawa, Shinozaki et al. 2002) (Figure 9). In 
the cytoplasm, the expression of I-Smads and E3 ubiquitin ligases (Smurf1 and Smurf2) further 
regulates the activity of R-Smads. Because the induction of I-Smads is controlled by members 
of the TGF-β superfamily, an auto-inhibitory feedback mechanism is embedded in TGF-β 




Figure 9 | A general mechanism of TGF-β receptor and Smad activation. At the cell surface, 
the ligand binds to the extracellular domains of T𝛽𝛽RII, which recruits and phosphorylates T𝛽𝛽RI. 
Activated T𝛽𝛽RI then phosphorylates the R-Smads. The R-Smads form a complex with a Co-
Smad and translocate into the nucleus, where they regulate transcription of target genes by 
interacting with DNA-binding factors. Smad6 or Smad7 can inhibit the activation of R-Smads. 
The E3 ubiquitin ligases (Smurf1 and Smurf2) mediate ubiquitination and degradation of R-
Smads. Figure modified from (Derynck and Zhang 2003). 
 The Smad3 and Smad4 complexes bind at a special DNA sequence which is called Smad-
binding element (SBE). It is a palindromic sequence of 8 bp (GTCTAGAC) (Zawel, Dai et al. 
1998). In contrast to Smad3 and Smad4, Smad2 complexes do not bind directly to DNA 
because of an extra exon (exon 3) in the MH1 domain (Figure 8) (Yagi, Goto et al. 1999) and 
instead, require interaction with other TFs (Gaarenstroom and Hill 2014). It is still unclear how 
Smad2 complexes find their DNA binding site. Other than Smad-dependent TGF-β signaling 
(known as canonical TGF-β signaling), the TGF-β superfamily can modulate other signaling 
pathways without intermediate Smads. 
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1.3.4 Non-canonical TGF-β signaling 
 The TGF-β superfamily signaling not only trigger cellular signaling that are converted by 
the five R-Smads, but also induce non-canonical TGF-β signaling in a Smad-independent 
manner. Non-canonical TGF-β signaling pathways are activated directly by ligand-occupied 
receptors to modulate downstream cellular responses. For example, the mitogen-activated 
protein kinase (MAPK) pathways, including the extracellular signal-regulated kinases (ERK), 
c-Jun amino terminal kinase (JNK), p38 MAPK, as well as the IκB kinase (IKK), 
phosphatidylinositol-3 kinase (PI3K) and Akt, and Rho family GTPases, are well-known non-
Smad signaling pathways (Zhang 2017). The T𝛽𝛽RII interacts with the Daxx,  a protein that 
actives JNK as well as programs cell death in epithelial cells and hepatocytes  (Perlman, 
Schiemann et al. 2001). This Daxx-JNK pathway also involves homeodomain-interacting 
protein kinase 2 (HIPK2) and induces apoptosis in human p53-deficient hepatocellular 
carcinoma cells (Hofmann, Stollberg et al. 2003). In mouse mammary epithelial (NMuMG) 
cells, a mutant T𝛽𝛽RI can induce the activation of p38 MAPK, which is required for TGF-β-
induced apoptosis and epithelial-to-mesenchymal transition (EMT) (Yu, Hebert et al. 2002). 
The ERK was also found to be one of the key pathways of EMT induction (Zavadil, Bitzer et 
al. 2001). Another non-canonical pathway activated by TGF-β is PI3K/Akt signaling pathway, 
which also contributes to TGF-β induced EMT in epithelial cells (Bakin, Tomlinson et al. 2000) 
and induction of proliferation in mesenchymal cells (Wilkes, Mitchell et al. 2005). Finally, Ras 
homolog family member A (RhoA) and Cell division cycle 42 (Cdc42) of the Rho family of 
GTPases are involved in the TGF-β induced membrane ruffles and stress fibers formation 
(Edlund, Landstrom et al. 2002). In the past few years, many studies have so far focused on 
TGF-β signaling networks. However, it is not yet understood how to establish the balance 
between Smad and non-Smad signaling pathways. 
1.3.5 The Nodal/Activin signaling pathway 
1.3.5.1 Nodal and Activin 
 Nodal and Activin are two members of the TGF-β superfamily that are able to send signals 
via the heterotetrameric receptor complex. Nodal has been first reported in retroviral mutation 
mice (Robertson, Bradley et al. 1986), and encodes a basement-signaling molecule to induce 
mesoderm formation and axial structures in the early development of mice (Zhou, Sasaki et al. 
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1993). Activin has been discovered to be a gonadal protein of several species (Vale, Rivier et 
al. 1986). It enhances the secretion of follicle-stimulating hormone (FSH) and expresses in 
various cell types at almost all development stages. 
 In mice, human beings and birds, there is only one member in Nodal (Zhou, Sasaki et al. 
1993). Other than that, there are three members in the zebrafish (Feldman, Gates et al. 1998, 
Rebagliati, Toyama et al. 1998, Sampath, Rubinstein et al. 1998) and five in Xenopus (Jones, 
Kuehn et al. 1995, Joseph and Melton 1997). Activin is a dimer composed of homodimers or 
heterodimers of Inhibin subunits (βa, βb, βc, βe). The different Inhibin subunits lead to the 
diversity of Activins. For example, two βa subunits form Activin A, βa and βb form Activin 
AB and two βb subunits form Activin B. 
 Nodal and Activin can bind T𝛽𝛽RI and T𝛽𝛽RII with other co-receptors (Table 1, Figure 10). 
The downstream effectors, Smad2/3 and Smad4, mediate signaling to the promoter region of 
target genes. The Smad proteins act as enhancers or repressors, leading to various cell type-
dependent effects. Many mechanisms can regulate the activation of Nodal and Activin. For 
instance, Lefty1/2 act as competitive inhibitors of Nodal in zebrafish (Thisse and Thisse 1999), 
Smad7 can inhibit the activation of Smad2/3, while BMPs (BMP3, BMP7) interact with Nodal 
at the level of dimeric ligand production (Yeo and Whitman 2001). Therefore, Nodal/Activin 
signaling is regulated by many molecules in both extracellular and intracellular compartments. 
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Figure 10 | Components of Nodal/Activin pathway. Extracellular ligand Nodal/Activin binds 
to T𝛽𝛽RI (ACVRIIA/IIB) and T𝛽𝛽RII (ALK4/7). Nodal requires additional binding of co-
receptor CRIPTO1 to form an activated receptor complex with T𝛽𝛽RI and T𝛽𝛽RII. These 
activated receptor complexes phosphorylate Smad2/3. Smad2/3 forms a complex with Smad4 
and enter the nucleus. Smad proteins target different genes by sequence-specific transcription 
factors, which are cell type dependent. Smad proteins can induce or inhibit the transcription of 
target genes and crosstalk with other signaling pathways in some cell types. Figure modified 
from (Pauklin and Vallier 2015). 
1.3.5.2 Roles of Nodal/Activin in development and cancer 
Nodal/Activin plays a crucial role in many development stages and cancers. For examples: 
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• Nodal/Activin signaling in mesoendoderm induction: Nodal signaling regulates 
endoderm differentiation by interacting with WNT and BMP signaling (Tam and 
Loebel 2007). It has been shown that differential activation of the Nodal signaling 
pathway acts essentially in establishing the anteroposterior pattern in the organizer 
(Gritsman, Talbot et al. 2000). Activin, working through its transient precursors, also 
delay the induction of endoderm in mES cells (Parashurama, Nahmias et al. 2008). 
• Nodal/Activin signaling in left-Right patterning: Nodal is the key morphogen in 
the regulation of the left-right axis specification (Brennan, Norris et al. 2002). Nodal 
produced in the node is required for the expression of left side-specific genes in the 
lateral plate mesoderm (Saijoh, Oki et al. 2003).  Interestingly, the studies of Nodal 
signaling pathway and its downstream genes, such as Pitx, suggest that the regulation 
of Nodal in the development of the LR axis is conserved (Namigai, Kenny et al. 
2014). 
• Nodal/Activin signaling in neural patterning: In zebrafish, the fate of cells in the 
organizer is transformed from dorsal mesoderm to neural ectoderm without Nodal 
signaling (Schier and Talbot 2001). In the absence of Nodal signaling, neural 
differentiation occurs concurrently in mouse epiblast cells and wild-type embryo, 
which suggests the role of Nodal in the inhibition of neural fate determination 
(Camus, Perea-Gomez et al. 2006). Moreover, Activin provides telencephalic neural 
precursors with a caudal ganglionic eminence (CGE) identity. This function is 
conserved between the mouse and humans (Cambray, Arber et al. 2012). 
• Nodal/Activin signaling and cancer: The mutation of multiple Nodal/Activin 
components leads to a cancerous effect, including T𝛽𝛽RI, T𝛽𝛽RII, Smad2 and Smad4 
(Massague 2008). Nodal is expressed in different tumors with overexpressed co-
receptor Cripto (Friess, Yamanaka et al. 1994, Kleeff, Ishiwata et al. 1998). It also 
increases the plasticity of tumor cells, which is important for tumor progression 
(Bodenstine, Chandler et al. 2016). Furthermore, an Activin α-inhibin acts as a 
tumor-suppressor gene of gonadal stromal cell proliferation (Matzuk, Finegold et al. 
1992), which means that Activin can be tumorigenic if it gets out of control. Both 
Nodal and Activin positively regulate self-renewal of pancreatic cancer stem cells 
(Lonardo, Hermann et al. 2011). 
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1. 4 Next-generation sequencing technologies 
1.4.1 Next-generation sequencing  
 Next-generation sequencing (NGS), also known as high-throughput sequencing (HTS), is a 
method that follows the first-generation sequencing technology Sanger method (Sanger, 
Nicklen et al. 1977). Compared with traditional methods such as PCR or Northern blot, NGS 
can output millions of reads in massively parallel sequencing. It also has the ability to produce 
an enormous volume of data cheaply. For example, it took 13 years and 3 billion dollars to 
accomplish the Human Genome Project by Sanger in 2003. Illumina, one of the NGS platforms, 
estimated the completion of 228,000 human genomes sequencing in 2014 and the price was as 
little as 1,000 dollars. Now, the NGS technologies apply to genome, transcriptome, DNA-
protein interactions and epigenome characterization.  
1.4.2 Overview of the Illumina sequencing method 
There are many NGS platforms these days, for instance Roche/454, Illumina/Solexa, 
Life/APG and Helicos BioSciences. Among them, Illumina takes up around 75% of the 
sequencing applications. Although the different NGS platforms have unique aspects in each 
step, they adhere to a similar fundamental methodology. The work of the NGS platforms can 
be divided into three basic processes: library preparation, amplification and sequencing. Here, 
we go through the NGS method based on the Illumina platform (Figure 11). 
i. Template preparation. The DNA sample is broken randomly into small fragments 
before the preparation of the template. Then, specialized adapters are added to both 
ends of the fragments. 
ii. Immobilization of strands on flow cell. The single-stranded fragments with added 
adapters are randomly attached to the inside surface of the flow cell channels. 
iii. Bridge amplification. After the loading of template fragments into the flow cell and 
the hybridization of the flow cell to the surface, the DNA fragment looks like a bridge. 
This is because both ends of the fragment are bound to the surface of the flow cell. 
Then, the unlabeled nucleotides and enzyme are added to the flow cell to initiate 




iv. Production and denaturing of double strands.  After bridge amplification, the 
double stranded DNA is denatured to leave single-stranded DNA separately anchored 
to the flow cell. 
v. Complete amplification. The bridge amplification is repeated until the fragments 
are amplified into clonal clusters. Finally, several million clusters of DNA fragment 
are generated on the flow cell.  
vi. Laser excitation. Before laser excitation, all of the reverse strands are washed out 
from the flow cell, leaving only the forward strands. When sequencing, four 
differently labeled fluorescent nucleotides are added into the flow cell one by one.  
The nucleotides are also labeled reversible terminators to avoid multiple additions. 
After adding, the unincorporated nucleotides are washed.   
vii. Signal image. The emitted fluorescence is imaged and each point on the image refers 
to a cluster. Next, the fluorescent labels are cleaved and the 3’-OH group is 
regenerated for the next round. For paired-end sequencing, the clusters will be 
regenerated and the process of sequence will be repeated for the reverse strand.  
viii. Sequencing. The laser excitation and signal imaging cycle is repeated to identify the 
sequence of bases in a fragment. The four colored images are translated into 
nucleotide, which is then exported into an output file. Besides the sequence of bases, 
the quality scores are also generated during a sequencing run. The quality score is a 
prediction of the probability of an error in case calling. It is used to assess the 






Figure 11 | Illumina sequencing workflow. i) Prepare genomic DNA sample; ii) Attach DNA 
to surface; iii) Bridge amplification; iv) Denature the double-stranded molecules; v) Complete 




The Life/APG sequencing platform, which is also known as SOLID, sequences by 
oligonucleotide ligation (Valouev, Ichikawa et al. 2008). The Roche/454 sequencing platform 
amplifies the DNA fragments using emulsion PCR on the surface of beads (Rothberg and 
Leamon 2008). Then, the beads are loaded onto the picotiter plate (PTP). Like Illumina, the 
Roche/454 sequences are also based on sequencing-by-synthesis (SBS) and PCR bridge 
amplification. The Illumina clusters, different from the Roche/454 beads that contain millions 
of copies, contain up to 1000 copies which are amplified from a single DNA fragment 
(Goodnow Jr 2014). All 1000 copies are sequenced together. The more laser excitation and 
signal imaging cycles we have, the more wrong signals we are likely to receive from the 
molecules. That is the main limitation of the Illumina sequencing length. The shorter read 
lengths of Illumina sequencing platform can be balanced by a higher throughput; 10 Gb - 1 Tb 
data can be produced by HiSeq 2500 system. 
Now, there are many different NGS methods for different applications. For example, 
methylation sequencing can provide insight into methylation patterns; whole-genome 
sequencing (WGS) is used to analysis entire genomes; Hi-C is a method for analyzing 
chromatin interactions. The key NGS methods for the datasets used within this thesis will be 
described in detail. 
1.4.3 RNA sequencing  
RNA sequencing (RNA-seq), also known as whole transcriptome shotgun sequencing, 
generates relative measures of mRNA and individual exon abundance in a sample at a given 
time point by NGS (Morin, Bainbridge et al. 2008). When using RNA-seq, there are some 
additional steps in the template preparation. After isolating the RNA of the sample by 
deoxyribonuclease (DNase), the RNA would be selected by poly(A) tails to catch only mRNA, 
deplete rRNA, capture RNA targets or keep total RNA of the sample. Once the RNA is obtained, 
it will be reverse-transcribed into cDNA for the following steps (Chu and Corey 2012). 
Compared with previous technologies such as microarrays, RNA-seq has significant 
advantages. It can better estimate the absolute transcript levels (Fu, Fu et al. 2009). RNA-seq 
currently supports a wide range of applications, which include: 
• Discovery of novel genes or splice junctions of expressed genes 
• Transcript quantification and expression comparison across cell types 
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• Gene annotation and functional analysis 
RNA-seq is not limited by prior knowledge as it can capture both known and novel features. 
In addition, RNA-seq can be applied to the species even if the reference sequencing is not 
available. However, RNA-seq still faces some challenges. In current sequencing platforms, the 
homopolymers, which play crucial roles in transcript metabolism, are hard to handle now 
(Hrdlickova, Toloue et al. 2017). The size limitations and sequencing sensitivity also need to 
be improved in the future.  
 1.4.4 ChIP-sequencing  
 Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is used to analyze 
the interactions between protein and DNA (Figure 12). In ChIP experiment, DNA sequences 
bound by a particular protein in cells are enriched. The cells are treated with formaldehyde to 
crosslink DNA-binding proteins to DNA. Then, the chromatin is beaked into 200–600 bp 
fragments by sonication or endonuclease for DNA-binding proteins and micrococcal 
nuclease (MNase) for histone modifications (Furey 2012). Next, a specific antibody against 
the DNA-binding protein is added to immunoprecipitate DNA-protein fragments. Finally, the 
crosslinks are reversed and the DNA is purified by phenol-chloroform extraction and ethanol 
precipitation. After this, the DNA can be used in the template-preparation step of NGS 
(Schmidt, Wilson et al. 2009).  
ChIP-seq can narrow the locations of the protein binding site to a range of a few tens of bp, 
and this unlimited dynamic range is one of its advantages. Because of its higher genome 
coverage, higher resolution and less noise, ChIP-seq is widely used in discovery of new 
regulatory elements, gene structure and the interactions between protein and DNA. ChIP-seq 
can capture DNA targets of specific TFs or histone modifications across the whole genome. 
Integrative analysis of ChIP–seq data, along with other data types like RNA–seq data, may 
clarify gene regulatory networks and the relationship between the transcriptome and TF 
binding. ChIP-seq is mainly limited by the alignability of reads to the genome. For this reason, 
the increasing read length can improve ChIP-seq coverage (Rozowsky, Euskirchen et al. 2009). 
Like any technology, ChIP-Seq has its artifacts. One of the biases is towards high GC content 
in fragment selection, which leads to false-positive peak calls (Teng and Irizarry 2017). In 
addition, the quality of the antibody and sample determine the value of ChIP-Seq. A sensitive 
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antibody will provide a high-level enrichment as compared to the background. For the quality 
of the sample, samples that are too small will bring about too few labels; while too many 
samples will cause the fluorescent labels to be too close to each other, resulting in lower data 
quality (Park 2009). In the future, not only experimental challenges that include antibodies 
selection need to be improved on, but also methods that can work with a small number of cells 
or signal cells are required. 
 
Figure 12 | Overview of a ChIP-seq experiment. The DNA targets for transcription factors 
or histone modifications are captured by chromatin immunoprecipitation (ChIP). After DNA 
purification, the ChIP-isolated DNA fragments are sequenced by next-generation 
sequencing to identify and quantify the sites bound by a protein of interest. Figure modified 
from (Park 2009). 
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1.4.5 Next-generation sequencing data 
The output of NGS is stored as FASTQ files. FASTQ format usually has four different 
information lines (Figure 13). The first line which begins with ’@’ contains the sequence name. 
The second line is formed by a nucleotide sequence which contains A, T, C, G, N (low quality). 
The third line begins with ‘+’ and is used to break the sequence and quality scores. The fourth 
line contains quality scores of the sequence as ASCII characters.  
 
Figure 13 | FASTQ file format example. 
There are multiple FASTQ sequences per file, maybe millions. The length of the sequences 
can be different in each file. Because the output data is complex and huge, it is necessary to be 
careful when analyzing sequencing data. 
1.4.6 Bioinformatics for next-generation sequencing  
 As shown above, NGS can be applied under various conditions to answer a variety of 
questions in different research fields. Because each read contains very little information, it is 
necessary to process NGS data using bioinformatics methods. The short reads of Illumina prove 
challenging for assembly software that are designed for Life/APG reads. New algorithms, 
programs and workflows that are specifically matched to short read sequence data are required. 
Open-source software accelerated the development of NGS data analysis (Pop and Salzberg 
2008). Currently, there are many data analysis software for different purposes. For mapping 
short DNA sequencing data to an existing reference genome, we can use BWA (Li and Durbin 
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2009), Bowtie (Langmead, Trapnell et al. 2009), MAQ (Li, Ruan et al. 2008) and GSNAP (Wu 
and Nacu 2010). For mapping RNA sequencing data, TopHat2 (Kim, Pertea et al. 2013), STAR 
(Dobin, Davis et al. 2013), Subjunc (Liao, Smyth et al. 2013) and kallisto (Bray, Pimentel et 
al. 2016) are good choices. The sequencing data also can be de novo assembled using Velvet 
(Zerbino and Birney 2008), IDBA (Peng, Leung et al. 2012), Trinity (Grabherr, Haas et al. 
2011) and ABySS (Simpson, Wong et al. 2009). These programs make it possible to quickly 
analyze large amounts of sequencing data in parallel. Software for identifying differentially 
expressed transcripts, such as RSEM (Li and Dewey 2011), edgeR (Robinson, McCarthy et al. 
2010) and Cufflinks (Trapnell, Roberts et al. 2012), helps researchers to compare differences 
between samples. 
Due to its advantages in quality, robustness and low noise, NGS is currently evolving into 
virtually every field of biological research, such as evaluation of genetic variations, RNA 
species distinction, epigenetic changes and so on. Through NGS, the gene expression dynamics 
in a signaling pathway can be quantified, which reflect the gene regulation results directly. 
1.5 Computational modeling of transcription dynamics 
 The abundance of cellular RNA is determined by the regulation of RNA production, 
processing, and degradation. Additionally, it varies over time due to the response to external 
or internal stimuli. A dynamic model that can describe the change rate of continuous variables 
is needed to study the transcription dynamics. Non-linear ordinary differential equations 
(ODEs) have been widely used in this area. For example, Ciira et al. fitted transcription 
dynamics to Pol II occupancy time course data using a probabilistic model (wa Maina, Honkela 
et al. 2014). Antti et al. showed that a splicing-associated delay can play a key role in RNA 
production. Their models joined the data of transcriptional activation and mRNA production 
(Honkela, Peltonen et al. 2015). Michal et al. used newly transcribed RNA data to estimate 
temporally observed RNA processing and degradation rates. They proposed that the variable 
degradation rates between genes contribute to the observed differences in the dynamic response 
(Rabani, Levin et al. 2011).  However, these models may not be suitable for the modeling of 
TGF-β superfamily induced gene expression due to the lack of TF dynamics.   
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Several researchers attempted to develop mathematical models to simulate the transcription 
process through TFs dynamics. Some studies prove that the binding of specific TFs can be used 
to predict gene expression in vitro (Kim and O'Shea 2008, Das, Dey et al. 2017, Choubey 2018). 
The TF titration effect has an important place in the expressions of TF-regulated gene pairs. 
Masayo Inoue and Mattias Rydenfelt et al. used it to predict the expression level of its regulated 
genes and relationship between TF–regulated gene pairs (Rydenfelt, Cox et al. 2014, Inoue and 
Horimoto 2017). All these models, which are based on predicted TF binding levels, may not 
reflect the TF activities of certain genes.  
Some research works found TF occupancy, as detected by ChIP-seq, correlated with 
changes in Pol II occupancy. For example, compared with RNA-seq data, correlation between 
TF occupancy and Pol II occupancy is stronger (Mokry, Hatzis et al. 2012). Forkhead box O3 
(FOXO3) acts as a transcriptional activator through Pol II recruitment (Eijkelenboom, Mokry 
et al. 2013). A straightforward mechanical relationship that explains how TF concentrations 





Aims & Objectives 
Activin/Nodal signaling is required for the maintenance of pluripotency in human ESCs, 
while high level Activin/Nodal regulates mesendoderm induction and left-right patterning 
(James, Levine et al. 2005, Fei, Zhu et al. 2010, Pauklin and Vallier 2015). How Activin/Nodal 
induces different responses to different cell fates remains unknown. Mathematics models that 
combine experimental and theoretical data are effective methods to investigate this. For 
example, some signaling pathways not only encode information into proteins concentration or 
position but also through changes in the dynamic of these concentrations (Nelson, Ihekwaba et 
al. 2004, Kell 2005). In these cases, computer models can provide additional insights into the 
dynamics of the network. In my thesis, based on the time course data of Pol II and Smad2 
chromatin bindings, we developed kinetic models to understand how different gene expression 
profiles are triggered by Activin signal.  
The main objectives of the proposed project are the following: 
 To develop models for simulating Activin induced gene expression profiles based 
on Smad2 and Pol II binding dynamics. Smad2 and Pol II time-course binding data 
was obtained by Coda et al. using ChIP-seq approach (Coda, Gaarenstroom et al. 2017). 
Different mathematical models were developed according to different hypotheses that 
describing the regulation of gene expression by Pol II, and Smad2. 
 To evaluate different models with the Akaike information criterion. Model selection 
methods were employed to evaluate different models and rank the fitting results. These 
results uncovered the role of Smad2 in the transcriptional regulation of Activin signaling 
for each gene separately.  
 To identify the main features that can predict the types of transcriptional responses 
trigged by Activin. Transcription dynamics can be associated with a variety of genetic 
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and epigenetic features. In this part, we set out to identify predictive features in 
transcriptional responses following Activin stimulation using logistic regression. This 







Materials & Methods 
3.1 Datasets 
In this thesis, we used two datasets that were downloaded from the NCBI Gene Expression 
Omnibus (GEO) data repository (GSE77262, GSE77488) (Shum, Jones et al. 2016, Coda, 
Gaarenstroom et al. 2017). An overview of these datasets is shown in Table 2. The first dataset 
(GSE77262) is a collection of RNA sequencing data that provide a genome-wide half-life 
analysis of mRNAs in the P19 cell line. After transfected first with siControl and then with 
actinomycin D, the RNA was isolated and sequenced at 0, 15, 105, and 225 minutes, post-
actinomycin D treatment. Another dataset used in the thesis are derived from the GSE77488 
dataset provided by Coda et al. In this dataset, the samples were first pre-treated with Activin 
receptor inhibitor (SB-431542) overnight. and then treated either the SB-431542 inhibitor (SB 
treated sample) or Activin. The RNA-seq, Smad2 ChIP-seq and Input ChIP-seq samples were 
isolated at 1 and 8 hours, following the Activin stimulation. The Pol II Ser2, H3K27ac and 
H3K9ac ChIP-seq samples were isolated at 1, 4 and 8 hours, following the Activin stimulation. 
In this dataset, specially, the Smad3 seems undetectable from western blot. Hence, the ChIP-







Table 2 |  Overview of the datasets used in this study 




Half-life analysis of 
mRNAs in mouse P19 
cell line 





stimulation or inhibition 
in mouse P19 cell line 
RNA-seq SINGLE 101 bp 
Pol II Ser2 ChIP-seq SINGLE 51bp 
Smad2 ChIP-seq SINGLE 51bp 
Smad2 Input ChIP-seq SINGLE 51bp 
H3K27ac ChIP-seq SINGLE 51bp 
H3K9ac ChIP-seq SINGLE 51bp 
 
3.2 Sequencing data analysis 
3.2.1 Data processing overview 
 The main procedure of sequencing data processing include the following steps: (i) quality 
control to remove adapter sequences and low-quality tails, (ii) sequence alignment to the 
genome, (iii) transcript abundance quantification, in which the number of aligned reads that 
overlap each gene or special region in the annotations are counted, (iv) data normalization for 




Figure 14 | Workflow for the processing of RNA sequencing data. The workflow begins 
with the quality control for the raw data. Then, the reads are mapped to the genome in order to 
obtain the number of aligned reads. Finally, the reads number per sample is normalized before 
downstream analysis. 
3.2.2 RNA-seq data processing 
3.2.2.1 Quality control 
 NGS can perform massively parallel sequencing. However, because of its complex structure 
and multiple processing steps, a careful analysis of NGS data is needed. The results can suffer 
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from a number of issues, such as poor sample quality, specific sequencing biases and 
inconsistent library preparation. In addition, the conditions of library construction could 
influence the sequencing bias (Ross, Russ et al. 2013). Therefore, it is necessary to control the 
quality of the NGS data from the beginning of the data analysis. There are many tools available 
for the quality control of NGS data. In this study, we used FastQC, which provides various 
statistics, including per base quality, GC content, sequence length, sequence duplication level 
and adapter types (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). The users can 
get a quick impression of the data conditions and the warnings that are reported based on its 
default values. One of the most important statistics is per base quality, which provides the 
Phred quality scores Q for each read position. Phred scores Q are defined as a property that is 
logarithmically related to the base calling error probabilities P (Ewing and Green 1998). 
𝑄𝑄 =  −10 𝑙𝑙𝑙𝑙𝑙𝑙10 𝑃𝑃 
For example, if Phred assigns a Q score of 20 (Q20) to a base, this is equal to the probability 
of an incorrect base call 1 in 100 times. This means that the base call accuracy is 99% and 
every 100 bp sequencing read may contain an error. 
 All of the RNA-seq data we used were first analyzed by FastQC (Figure 15). The half-life 
RNA-seq data have good qualities, while the time-course RNA-seq data from GSE77488 have 






Figure 15 | Per base quality plot of FastQC. The median (red) and mean (blue) Phred scores 
are shown on the plots. A. The half-life RNA-seq data (SRR3126197). B. The time-course 
RNA-seq data (SRR3138964). 
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3.2.2.2 Alignment and quantification 
After quality control, all RNA-seq reads need to be aligned to the genome. This alignment 
arranges the sequences to identify the location from which the reads originated (Garber, 
Grabherr et al. 2011). Because of the introns, the alignment of the RNA-seq reads needs to be 
distinguished from the intron-spanning reads, which spams at least one intron. The alignment 
is a time-consuming step during mapping. Here, we aligned RNA-seq reads and the mouse 
reference genome (GRCM38) using the HISAT2 (Kim, Langmead et al. 2015) aligner. The 
HISAT2 divides these exon-spanning reads into four categories: “(1) long-anchored reads, 
which exhibit at least 16 bp in each of the two exons; (2) intermediate-anchored reads, which 
exhibit 8–15 bp in one exon; (3) short-anchored reads, with just 1–7 bp aligned to one of the 
exons; and (4) the reads spanning more than two exons” (Figure 16A). In a simulated human 
RNA-seq data set, about 25.1% of the reads span two exons with more than 15bp anchors in 
both exons and about 12.4% of the reads span at least two exons with intermediate or short 
anchors, which are hard to be mapped to a unique location in the genome (Figure 16B).  
 
Figure 16 | HISAT RNA-seq reads types and their relative proportions. A. Five types of 
RNA-seq reads: i) M, exonic read; ii) 2M_gt_15, junction reads with long; iii) 2M_8_15, 
junction reads with intermediate; iv) 2M_1_7, junction reads with short; and v) gt_2M, junction 
reads spanning more than two exons. B. Relative proportions of different types of reads in the 
20 million 100-bp simulated read data. Figure modified from (Kim, Langmead et al. 2015). 
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HISAT2 solves the challenging spliced-alignment problems using hierarchical indexing, 
which is based on the Burrows-Wheeler transform (BWT) (Burrows and Wheeler 1994) and 
the Ferragina-Manzini (FM) index (Ferragina and Manzini 2000). BWT is a reversible 
permutation of the characters in a text (Figure 17). It uses a matrix to re-order the reference 
sequence and the matrix has a property called 'last first (LF) mapping', which means the ith 
occurrence of character X in the last column corresponds to the same text character as the ith 
occurrence of X in the first column (Langmead, Trapnell et al. 2009). HISAT2 applies a whole-
genome FM index to anchor each alignment and a number of local FM indexes in order to 
rapidly extend these alignments. As a result, HISAT2 is a highly accurate and efficient system 
for sequencing data alignment. 
 
Figure 17 | The Burrows-Wheeler transform. String T is looped to generate seven strings, 
which are then sorted in lexicographic order. After sorting, the last column gives the BWT 
string. 
All of the 101 bp RNA-seq reads were aligned to the HISAT2 GRCm38 index that was 
downloaded from the HISAT website. This index contains the Hierarchical Graph FM index 
for GRCm38. After alignment, the mapped reads were counted by ReadCounter 
(http://www.genefriends.org/ReadCounter) (Table 3). Only the reads mapped uniquely to 
exonic regions of one gene were counted, the ambiguous reads were not used in further analysis. 
The mean RNA-seq gene alignment rate was 25.0 million reads for half-life of mRNA data 




Table 3 | Mapping results of RNA-seq samples. 
Dataset SRR number Time point 
Total number of 
reads 
Number of reads 
uniquely mapping to 






mouse P19 cell 
line 
SRR3126196 0min_1 19,296,773 16,158,126 (83.73%) 
SRR3126197 0min_2 26,666,632 23,070,791 (86.52%) 
SRR3126200 15min_1 27,258,464 22,749,449 (83.46%) 
SRR3126201 15min_2 20,580,569 17,750,958 (86.25%) 
SRR3126204 105min_1 19,437,322 17,325,594 (89.14%) 
SRR3126205 105min_2 27,370,733 24,931,443 (91.09%) 
SRR3126208 225min_1 24,341,837 22,221,103 (91.29%) 







mouse P19 cell 
line 
SRR3138964 SB-431542_1 28,894,091 22,506,012 (77.89%) 
SRR3138965 SB-431542_2 33,754,546 26,236,341 (77.73%) 
SRR3138966 1h Activin_1 52,349,182 40,329,813 (77.04%) 
SRR3138967 1h Activin_2 55,390,050 42,891,396 (77.44%) 
SRR3138968 8h Activin_1 52,536,698 40,980,998 (78.00%) 




3.2.2.3 Data normalization 
After the alignment of reads, it is possible to detect the expression of a certain RNA based 
on the count of reads. In RNA-seq, it has been found that the reads count is linearly related to 
the abundance of the target transcript (Mortazavi, Williams et al. 2008). However, due to 
different sample sizes or sequencing libraries, we need to normalize the number of aligned 
reads before analysis. Mapped reads of mRNA half-life samples were normalized by the reads 
count of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene, which is a stable 
transcript, and used as a control in this analysis. Mapped reads of time-course RNA-seq 
samples were normalized by the DESeq package from Bioconductor (Anders and Huber 2010). 
The DESeq package is based on the negative binomial distribution assumption, which assumes 
that most genes are not differentially expressed and these genes should have similar read counts 
among different samples. The DESeq package compares and scales all reads count of the 
samples to validate the hypothesis (Dillies, Rau et al. 2013). This approach helps to identify a 
small number of differentially expressed genes which have a strong effect on the total reads 
count. 
To determine the differentially-regulated genes, we converted the Activin stimulation data 
into fold change (FC) by normalizing it against the SB-431542 treated sample.  To identify the 
differentially-regulated genes, we set the false discovery rate (FDR) threshold with a value of 
0.05 and a fold change cutoff of 2 Furthermore, genes with lower than 30 reads across all 
samples were discarded, as they appear as background noise. In total, 198 differentially-
regulated genes were identified. The corresponding mRNA half-life data were normalized to 
the value of the 0min sample and converted into FC values. 
3.2.3 ChIP-seq data processing 
3.2.3.1 Quality control 
 All of the ChIP-seq reads were quantified by FastQC, and none of them has a low per-
sequence quality. Therefore, the ChIP-seq data have a high quality for downstream analysis.  
3.2.3.2 Alignment 
 Because of the short sequencing length, the ChIP-seq reads and the mouse reference genome 
(GRCM38) were aligned using Bowtie (Langmead, Trapnell et al. 2009) (Table 4). Bowtie 
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applies the BWT and the FM index to map the NGS data. During mapping, the maximum 
mismatch was set to 2 for a seed length of 51 bp. Uniquely mapped reads were used for further 
analysis. 
Table 4 | Mapping results of ChIP-seq samples. 
Strategy SRR number Time point Total number of reads 
Deduplication unique  
mapped reads 
Pol II Ser2 
ChIP-seq 
SRR3096935 SB-431542_1 36,330,127 22,351,909 (64.19%) 
SRR3096936 SB-431542_2 68,651,414 42,259,967 (64.23%) 
SRR3096937 1h Activin_1 61,449,305 39,808,852 (66.54%) 
SRR3096938 1h Activin_2 43,241,380 28,063,594 (66.60%) 
SRR3096939 4h Activin_1 57,786,670 36,941,071 (66.31%) 
SRR3096940 4h Activin_2 52,770,475 33,416,122 (65.12%) 
SRR3096941 8h Activin_1 63,973,606 40,229,252 (65.44%) 




SRR3138984 SB-431542_1 79,719,094 53,319,157 (66.88%) 
SRR3138985 1h Activin_1 64,969,548 44,115,539 (67.90%) 
SRR3138986 8h Activin_1 61,611,461 41,516,897 (67.39%) 
Smad2 
ChIP-seq 
SRR3138989 SB-431542_1 61,905,267 42,508,561 (68.67%) 
SRR3138990 1h Activin_1 78,813,534 41,913,149 (53.18%) 
SRR3138991 8h Activin_1 64,295,840 36,933,125 (57.44%) 
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Strategy SRR number Time point Total number of reads 




SRR3096955 SB-431542_1 62,580,321 43,653,788 (69.76%) 
SRR3096956 SB-431542_2 70,930,705 49,778,672 (70.18%) 
SRR3096957 1h Activin_1 59,096,422 41,475,768 (70.18%) 
SRR3096958 1h Activin_2 46,577,906 33,978,972 (72.95%) 
SRR3096959 4h Activin_1 83,127,468 57,180,028 (68.79%) 
SRR3096960 4h Activin_2 64,634,339 45,690,199 (70.69%) 
SRR3096961 8h Activin_1 48,272,522 34,050,852 (70.54%) 
SRR3096962 8h Activin_2 96,611,571 65,655,485 (67.96%) 
H3K9ac 
ChIP-seq 
SRR3096965 SB-431542_1 59,781,351 40,229,769 (67.29%) 
SRR3096966 SB-431542_2 61,309,061 40,820,014 (66.58%) 
SRR3096967 1h Activin_1 67,570,064 45,646,158 (67.55%) 
SRR3096968 1h Activin_2 72,466,133 47,932,200 (66.14%) 
SRR3096969 4h Activin_1 62,747,501 41,969,430 (66.89%) 
SRR3096970 4h Activin_2 57,600,750 37,943,964 (65.87%) 
SRR3096971 8h Activin_1 80,545,904 54,843,433 (68.09%) 
SRR3096972 8h Activin_2 81,769,081 53,229,993 (65.10%) 
3.2.3.3 Peak calling 
 After sequencing reads are mapped to the genome, the next step for Smad2 ChIP-seq 
samples is to identify enriched regions (Figure 18). The enriched regions (so-called ‘peaks’) 
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are enriched in the ChIP sample relative to the control and with statistical significance. They 
are candidates of the binding locations of the protein of interest. These regions are estimated 
by the number of reads in a given size window and assessed by criteria such as enrichment over 
the control and minimum read density. The Poisson model was used previously to access the 
significance of peaks. The corresponding hypothesis is that if the reads were randomly 
distributed among the genome, then the probability of observing a peak with a coverage depth 
of at least H reads can be given by a sum of Poisson probabilities (Robertson, Hirst et al. 2007, 







 whereby λ is the global coverage level which is given by: (read length * number of aligned 
reads)/mappable genome length. 
 Unfortunately, the genomic background is not uniform in the ChIP-seq data (Zhang, 
Rozowsky et al. 2008). This bias may be explained by the numerous variations of genome 
copies, chromatin structure and sequencing or mapping biases (Zhang, Liu et al. 2008). 
Because of this,  we used MACS (Zhang, Liu et al. 2008)  for peak calling. The MACS program 
implements a two-step approach. First, it determines a fixed size of windows and locates 
enrichment regions which have more reads than the fold-enrichment of the windows as relative 
to a random distribution of genome-wide reads. The MACS program selects 1000 of these 
regions randomly and aligns them using the center of their Watson and Crick peaks. The 
distance between the summits of the Watson and Crick peaks are defined as ‘d’. All of the 
reads are shifted by d/2 toward the 3’ ends to the most probable site of protein-DNA interaction. 
In the second step, the MACS program slides 2d windows across the genome and calculates 
the enrichment (Poisson distribution p-value based on local λ) to find candidate peaks. In an 
evaluation of peak-calling algorithms, MACS shows great estimates of precise binding location 




Figure 18 | Strand-specific profiles at enriched sites. The reads aligned to the reference 
genome result in either sense (blue) or antisense (red) peaks. These two peaks show the target 
protein binding regions. Each mapped read is extended by an estimated fragment size to create 
an approximate distribution of all reads. Figure modified from (Park 2009). 
 We ran the MACS program with a q-value filter of 0.05 and other parameters were set as 
default. After peak calling, no peaks were detected in the SB-431542 treated sample. By 
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comparing the 1h and 8h Activin stimulation samples to the input samples, 859 and 4410 peaks 
of significant Smad2 enrichment were defined, respectively. The peaks located on 
mitochondrial DNA were removed before further analysis. 
3.2.3.4 Peak annotation 
 To define the activity loci that are applicable across the different time points, all of the peaks 
were merged into one peak if there was at least 1 bp overlap between two peaks. 1,298 peaks 
overlapped and the mean length of the overlap was 344 bp (Figure 19).  
 
Figure 19 | Merging Peaks from peak calling results. A. If the two peaks have more than 1 
bp overlap, they will be merged into a new peak. B. The number of peaks in each condition is 
shown in the Venn diagram. C. The distribution of the lengths of peak overlaps. 
The merged peaks were annotated to the nearest gene within 100 kb from the gene’s 
transcription start site/transcription termination site (TSS/TTS) using PAVIS (Huang, 
Loganantharaj et al. 2013) (Figure 20). 4,339 of 4,615 (94.02%) merged peaks were 
successfully associated with genes. The majority of binding events occur at regions distance 





Figure 20 | Distribution of peaks in relation to genes. The plot shows the genomic 
distribution of peaks based on annotation results. The mouse genome was subdivided into 
upstream, 5’ UTR, exons, introns, 3’ UTR, downstream and other regions. Subsequently, the 
peaks were counted for each region. The distribution of peaks is in a similar fashion over the 
three conditions.  
3.2.3.5 Quantification 
 The ChIP-seq data were counted differently using bedtools (Quinlan and Hall 2010) (Figure 
21). We quantified gene Pol II activity by summing up the read counts in the last 20% of the 
gene body to the 3’ end. The gene body was defined as the gene range in the reference genome. 
Smad2 activity is quantified by summing up the reads across the merged peaks that were 
annotated to the same gene. The H3K27ac and H3K9ac counts are in the region of +/- 2,000 






Figure 21 | Quantification regions for different data types. The coverage profiles and 
quantification regions for RNA-seq reads (blue), Pol II ChIP-seq reads (green), Smad2 ChIP-
seq reads (yellow) and histone modification ChIP-seq reads (rose) were visualized using the 
Integrative Genomics Viewer (IGV) (Robinson, Thorvaldsdottir et al. 2011). 
3.2.3.6 Data normalization 
 For Smad2, H3K9ac and H3K27ac ChIP-seq data, the raw read counts were normalized to 
reads per million (RPM). For Pol II ChIP-seq data, the raw read counts were normalized by 
DESeq2. The ChIP-seq data were compared against the SB-431542 sample and converted into 
FC values. 
3.3 Summary 
In this chapter, we analyzed the raw sequencing data and selected different analysis methods 
depending on the types sequencing data. In the workflow, we mapped the sequencing data to 
the genome and converted the sequencing data into FC value that are related to the baseline of 
the sample after we screened the data quality and homogenized the alignment results. Based 
on the FC, we identified 198 differentially-regulated genes after Activin stimulation and 
annotated 70 target genes with Smad2 binding peaks (Figure 22). This provides valuable data 
for the subsequent modeling analysis (Chapter 4). In addition, we annotated the Smad2 peaks 
and discovered that the percentage of annotation of Smad2 binding sites did not change much 
across different time points. Furthermore, most of the Smad2 peaks were annotated far apart 










Kinetic modeling of the transcriptional 
responses to the Activin signal 
4.1 Introduction 
A major objective of this chapter is to understand the transcriptional responses of P19 mouse 
cells with Activin stimulation. After selecting differentially-regulated genes (Chapter3), we 
started to develop mathematical models for explaining different dynamics of gene expressions 
induced by Activin. In the absence of Smad2 activity, the transcriptional dynamics of most 
genes cannot be explained just by the differences of Pol II occupancy and/or mRNA half-life. 
After fitting different models to the transcriptional data of differential-regulated genes, we 
selected the best model for each gene based on Akaike information criterion (AIC). The model 
selection results suggested that: (i) the mechanism by which Activin regulates gene expression 
is diverse and has different regulatory approaches for different genes, (ii) the relationship 
between Pol II binding activity and mRNA expression level is non-linear, and (iii) some of 
target genes do not require local Smad2 chromatin binding. 
4.2 Activin induces multiple temporal patterns of gene 
expression 
 Through analysis of the RNA-Seq data, we identified 198 differentially-regulated genes 
relative to the SB-431542-treated state. Due to the use of different sequence alignment tools 
and strict filters for gene identification, we had fewer differentially-regulated genes than the 
original paper. These expressions were converted into log2FC values (relative to SB-431542) 
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for each time point. Gene ontology analysis showed the enrichment of these differentially-
regulated genes for TGF-β signaling pathway and development processes (Ashburner, Ball et 
al. 2000, The Gene Ontology 2019) (Table 5). We related how the Pol II occupancy changed 
over time relative to the transcription as measured by RNA-seq (Figure 23). The differentially-




Table 5 | Gene ontology enrichment analysis of differentially-regulated genes. The data 
was analyzed by GO Enrichment Analysis (Mi, Muruganujan et al. 2019). 
  PANTHER Pathways ID In Data 
Fold 
Enrichment P-value FDR 
1 TGF-beta signaling pathway  P00052 7 9.91 1.07E-05 8.79E-04 
2 Gonadotropin-releasing hormone receptor pathway P06664 8 4.63 4.29E-04 2.35E-02 
  Reactome pathways  ID In Data 
Fold 
Enrichment P-value FDR 
1 MAPK family signaling cascades 
 R-MMU-
5683057 11 5.52 7.57E-06 1.22E-02 
2 RAF/MAP kinase cascade  R-MMU-5673001 10 5.64 1.65E-05 1.34E-02 
3 MAPK1/MAPK3 signaling  R-MMU-5684996 10 5.5 2.03E-05 1.09E-02 
4 Signaling by TGF-beta family members  
R-MMU-
9006936 6 8.87 8.36E-05 3.38E-02 
5 Signaling by BMP  R-MMU-201451 4 19.42 8.40E-05 2.72E-02 
  GO biological process  ID In Data 
Fold 
Enrichment P-value FDR 
1 Regionalization  GO:0003002 29 11.3 2.17E-21 3.42E-17 
2 Pattern specification process  GO:0007389 31 9.41 1.19E-20 9.35E-17 
3 Tissue development GO:0009888 53 4.35 2.59E-20 1.36E-16 
4 Animal organ morphogenesis  GO:0009887 42 5.68 5.41E-20 2.13E-16 




Figure 23 | Hierarchically-clustered heatmap for each differentially-regulated gene 
showing log2FC values, relative to SB-431542 for gene expression, as determined by 
RNA-seq (left), Pol II Ser2P binding level (right).  
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4.3 Estimation of transcriptional activity using Gaussian 
process regression 
 Due to only limited mRNA data points are available, fitting models to these data may cause 
overfitting, which is "the use of models or procedures that violate parsimony-that is, that 
include more terms than are necessary or use more complicated approaches than are necessary" 
(Hawkins 2004).To overcome this issue, we modeled mRNA half-life and Activin time series 
data as a Gaussian process (GP) prior distribution that is nonparametric and avoids assuming a 
specific shape (Rasmussen and Williams 2006). A GP distribution on f is written as: 
 𝑝𝑝(𝑓𝑓) = 𝐺𝐺𝑃𝑃(𝑓𝑓;  µ,𝐾𝐾) (1) 
It is completely specified by its first two moments: the mean function µ and covariance function 
K.GP is a collection of random variables. This means that a GP is a Gaussian distribution over 
functions. In recent studies, GPs have been applied in biological dynamical systems (Gao, 
Honkela et al. 2008, Honkela, Girardot et al. 2010, Liu and Niranjan 2012). 
 In this study, we used a GP to model the temporal dynamics of the mRNA data. The used 
GP kernel function is the squared exponential covariance function with the length scale l, as 
shown below: 
 




Additionally, the mean function was set to zero. The parameters of a prior distribution such as 
the length scale l, the output scale λ and the noise variance σ2, are called hyperparameters θ, 
which denotes the vector of the hyperparameters and is chosen by maximizing the Gaussian 
likelihood as shown below: 
 
𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝑙𝑙𝐺𝐺𝑘𝑘𝑒𝑒𝑙𝑙𝐺𝐺ℎ𝑙𝑙𝑙𝑙𝑜𝑜(𝑡𝑡) =




𝐺𝐺𝑠𝑠𝑠𝑠𝑡𝑡(2 ∗ 𝜋𝜋 ∗ 𝐺𝐺𝐺𝐺2)
 (3) 
Where y is the mean and sn is the standard deviation. 
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 Here, we used the GPML function of MATLAB for Gaussian process regression models on 
mRNA-seq data (Rasmussen and Nickisch 2010) (Figure 24). With the Gaussian process 
regression models, we sampled 16 mRNA half-life data points (from 0h to 3.75h, the data was 
taken every 15min) and 17 Activin induced gene expression data points (from 0h to 8h, the 
data was taken every 30min). 
 
Figure 24 | An example of the mRNA half-life data sampled from the GPR model. For 
each gene, we used the GPML function to simulate the data. Solid green and blue lines show 
the data for mRNA data after Activin stimulation and mRNA half-life data, respectively.  The 
shadow zones indicate associated 95 confidence interval regions.  
4.4 A simple kinetic model for transcriptional responses to 
Activin 
To understand how TGF-β signaling regulates transcripts dynamics, A system of ordinary 
differential equations (ODE) model is widely used for simulating the kinetics of gene 
expression (Ropers, de Jong et al. 2006). We first developed a simple model to fit gene 
transcriptional data sets. This model assumes that mature mRNA levels are determined by a 
first-order integration of production and degradation rates over time (Rabani, Levin et al. 2011).  
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 In this model (model 1), the changes of mRNA (x) amount is determined by mRNA 
production rate and degradation rate.  The mRNA production rate is assumed to be proportional 




=  𝐺𝐺 ∗ 𝑃𝑃 − 𝛾𝛾 ∗ 𝑑𝑑 (4) 
The activity of Pol II for a certain gene is measured by the binding signal of Pol II Ser2. The 
mRNA abundance is measured by normalized RNA-seq reads mapped onto the gene exons. As 
the data were converted to fold change (FC) values, we transform equation (4) to a 
dimensionless equation by rescaling the variables to their initial values according to equation 

















= 𝛼𝛼 ∗ 𝑃𝑃 − 𝛾𝛾 ∗ 𝑥𝑥 
 
(6) 
Here, 𝛼𝛼 is a scaling factor for the transformation. The variables x and P denote fold change of 
mRNA and Pol II activity for a gene, respectively. The parameter γ determines the mRNA half-
life. For mRNA, an exponential decay can be described by 
 𝑁𝑁(𝑡𝑡) = 𝑁𝑁0 ∗ 𝑒𝑒−𝛾𝛾𝛾𝛾 (7) 
where N0 is the initial mRNA abundance, N(t) is the remaining mRNA at time t after 
degradation. For each gene, the half-time (t1⁄2) is defined as the time point when N(t)  is a half 
of N0. The mRNA half-life can be calculated from γ: 
 










= −𝛾𝛾 ∗ 𝑥𝑥 (9) 
 We assume that gene transcriptions are in a steady state in the baseline sample (0h), which 
means that the mRNA production rate is equal to the degradation rate for each gene (α * P – γ 
* x = 0). Because the variables are transformed to fold changes, P and x at 0h equal to 1. We 
can obtain α = γ.  
We applied the Data2Dynamics (D2D) tool to fit this simple ODE model (model 1) to 
corresponding data for differential regulated genes (Raue, Schilling et al. 2013, Raue, Steiert 
et al. 2015). The range of estimated parameter values were listed in Table 6.  
Table 6 | The ranges of estimated parameter values used in D2D. 
Parameter symbol Meaning Range Ref. 
γ mRNA half-life 10-1.6~10-3.6 min-1 
(Schwanhausser, 
Busse et al. 2011) 
 
After simulation, the simulated results would be checked by a statistical measure called chi-
square (x2) to estimate how well this model fits the observations (Press, Flannery et al. 1992). 
The chi-square is based on chi-square distribution (a special kind of gamma distribution) and 
it is defined as the sum of the squares of independent standard normal random variables 
(Bennett and Franklin 1954): 
 






Where in our model, xi is the fold change of mRNA, yi is the simulated data, and σi is the 
standard deviation for xi. When the sample size is large, the chi-square goodness-of-fit statistic 
is approximately a chi-square random variable. It is commonly used to test whether the given 
data are well described by the hypotheses. After calculating the chi-square distribution, the p-
value, which refers to the probability of observing a more extreme value than the simulated 
data in the chi-squared distribution, can be evaluated based on degrees of freedom (df). We 
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used a p-value filter of 0.05 to evaluate whether the model can fit the data for the corresponding 
gene. 
As a result, most target genes cannot be explained by this model. Only 21 of 198 (10.6%) 
target genes can be fitted by this simple linear model.  This result indicate more complicated 
models are required to explain the observed gene transcription data sets.  
4.5 Delays cannot explain transcription kinetics 
 Recent studies have shown that RNA splicing can be the timing-limited step of mRNA 
production (Hao and Baltimore 2013). A splicing-associated delay can play a key role in RNA 
production. We next developed a delay model to account for the processing delay between the 
Pol II activity and final mRNA production (Honkela, Peltonen et al. 2015) (Eq. 9). 
 𝑜𝑜𝑥𝑥
𝑜𝑜𝑡𝑡
=  𝛼𝛼 ∗ 𝑃𝑃(𝛾𝛾−𝜏𝜏) − 𝛾𝛾 ∗ 𝑥𝑥 (11) 
The new parameter τ is defined as the delay time during mRNA processing. 
 It seems that the delay model could not fit more genes than the dynamic model. Only 21 of 
198 (10.6%) target genes can be fitted by this delay model. In addition, the estimation of 
parameter τ shows that the majority of genes do not have a long delay time (Figure 25). The 
estimated delay time for most of genes (65.66%) is less than 10 min.   
 
Figure 25 | Distribution of delay from target genes. 
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 The results show that the delay model in equation (11) cannot explain the transcription 
dynamic of the target genes. We analyzed the FC of mRNA and Pol II at the 8h time point. If 
we assume that gene expression at 8h after Activin stimulation is approximately in a steady 
state, the FC of mRNA would approximately equal to FC of Pol II at 8h, when α = γ. However, 
for most of genes, the FC of mRNA is much higher than the FC of Pol II (Figure 26). This may 
be explained by the variations of Pol II elongation rates among different genes. It has been 
reported that the Pol II density of the gene body has a striking correlation with the elongation 
rate (ρ = 0.46; p = 4.5 × 10−10) (Danko, Hah et al. 2013).  
 
Figure 26 | The FC of mRNA is stronger than the FC of Pol II.  A. Point plots showing 
normalized (log2) mRNA FC and Pol II Ser2P FC at 8h.The orange line represents the graph 
‘y = x’. B. Distribution of mRNA FC/Pol II FC. 
4.6 A revised model with a non-linear relationship between 
RNA polymerase II density and mRNA expression 
 In order to estimate the elongation rate via Pol II occupancy, we used Hill functions to model 








− 𝛾𝛾 ∗ 𝑥𝑥 (12) 
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Where Kp is the FC of Pol II that corresponds to half of the maximum mRNA production rate 
and np is the Hill coefficient. The bound for Kp is set based on the Pol II FC range and np is set 
from 1 to 5. The non-linear Pol II model can fit 66 genes, which explains about 34.34% of all 
198 differentially regulated genes.  
In summary, due to the different magnitude of fold changes between Pol II density and 
mRNA, the linear or delay models can only fit the data for a few target genes. While the model 
using the nonlinear model can largely increase the number of fitted genes from about 10% to 
34%.  Further regulations would need to be taken account in order to fit mRNA data for other 
genes.   
4.7 Kinetic models for the expression of 70 genes with 
Smad2 binding density 
 Previous work has shown that Smad protein play important role in regulating gene 
expression in the TGF-beta signaling. We next aimed at developing new models that include 
the regulation of mRNA production by Smad2 binding. After annotating the Smad2 peaks to 
the closet gene within 100 kb from the gene’s TSS/TTS already. We found the majority of 
these peaks are located within a window of 10kb or even only 1kb around the TSS of their 
regulated genes (Figure 27). We identified 70 genes that are associated with 133 Smad2 peaks 
after Activin stimulation. For further analysis, we first compared the FC of Smad2 activity at 
different times with the mRNA abundance and Pol II activities of the target genes (Figure 28). 
Although it seems that both mRNA and Smad2 reached its respective highest level at the 8h 
time point, the Smad2 binding level is not correlated with the transcription abundance. This 




Figure 27 | The density of Smad2 peaks and their distance from the annotated TSS of the nearest regulated target gene within a ± 10kb 




Figure 28 | Hierarchically-clustered heatmap for each target gene showing log2FC values, 
relative to SB-431542 for gene expression, as determined by RNA-seq (left), Pol II Ser2P 





Figure 29 | An overview of the generative model with Smad2 activities. 
Through the regulation of Smads, TGF-β superfamily signal can induce activation or 
repression of target genes (Ross and Hill 2008). In addition, many researches have shown that 
TGF-β superfamily can regulate transcription processes by mRNA alternative splicing or 
mRNA degradation through Smads (Chen, Zhou et al. 2016, Tripathi, Sixt et al. 2016). 
Therefore, we hypothesize that Smad2 could have both positive or negative effects on mRNA 
production or degradation steps (Figure 29). Correspondingly, we devloped 8 new models, 

























































































� ∗ 𝑥𝑥 (20) 
Where S is the Smad2 binding signal. The meaning and bounds of model parameters are shown 












Table 7 | Bounds for different model parameters. We list the values of the lower and the 
upper bounds. The K was set based on the FC values of ligand. 
Parameter 
symbol Description 
Lower bound Upper bound 
γ mRNA half-life 10-3.6 min-1 10-1.6 min-1 
β Scale of Smad2 estimates 0.01 min-1 100 min-1 
Kp Activation coefficient of Pol II FC 0.01 160 
Ks Activation coefficient of Smad2 FC 0.1 10 
np Hill coefficient of Pol II FC 1 5 
ns Hill coefficient of Smad2 FC 1 5 
 
As with the previous models, we used the chi-square distribution and the p-value to evaluate 
model fitting results. After incorporating Smad2 in the models，we were able to obtain good 
model fits for 59 out of 70 (84.23%) genes, which has Smad2 binding peaks. In summary, after 
Smad2 binding signal is added to the models, the fitting results of target genes greatly improved. 
It can be concluded that Smad2 plays an important role in gene regulation. However, many 
genes can be fitted by more than one model. In the next stage, we would like to choose the best 
order for the mRNA regulation of each gene. 
4.8 Model selection using Akaike's Information Criterion 
  Now we have developed a pool of kinetic models to fit the mRNA datasets for Activin 
regulated genes, we next ask which model is most likely true given the data. The model with a 
large number of parameters may fit the data better, but it has a high risk of overfitting. To select 
the best model, we used Akaike Information Criterion (AIC) (Burnham, Anderson et al. 2002), 
which is defined as 
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 𝐴𝐴𝑃𝑃𝐴𝐴 = −2(𝑙𝑙𝑙𝑙𝑙𝑙 − 𝑙𝑙𝐺𝐺𝑘𝑘𝑒𝑒𝑙𝑙𝐺𝐺ℎ𝑙𝑙𝑙𝑙𝑜𝑜) + 2𝐾𝐾 (21) 
Where K is the number of parameters.  
If the sample size is small, the AIC may select the model that overfits the data (McQuarrie 
and Tsai 1998). To address this problem, AICc was developed by Sugiura in 1978, which is  
AIC with a correction for small sample sizes. 
 
𝐴𝐴𝑃𝑃𝐴𝐴𝑐𝑐 = 𝐴𝐴𝑃𝑃𝐴𝐴 +  
2𝐾𝐾2 + 2𝐾𝐾
𝐺𝐺 − 𝐾𝐾 − 1
 (22) 
Where n is the sample size. If n / K < 40, it is recommended to use AICc (Burnham, Anderson 
et al. 2002). With least squares fitting, the log-likehood is calculated by the residual sum of 
squares, which is called RSS, 









𝐴𝐴𝑃𝑃𝐴𝐴𝑐𝑐 = 𝐺𝐺𝑙𝑙𝑙𝑙𝑙𝑙 �
𝑅𝑅𝑆𝑆𝑆𝑆
𝐺𝐺
� + 2𝐾𝐾 +  
2𝐾𝐾2 + 2𝐾𝐾
𝐺𝐺 − 𝐾𝐾 − 1
 (24) 
Based on AICc value, we can select the model that has minimal information loss. However, 
the model with the smallest AICc value may not always be the best one.  
To put AICc into practice, we also need to estimate the information loss among the models 
to find the probability for each model as the best model. Let’s take the set of m models as an 
example. First, we need to account for the AICc differences Δ over all of the candidate models 
in the sets. The AICc difference Δi is the AICc of model i minus the AICc of the best model. 
The AICc differences are easy to interpret and provide a quick comparison of the candidate 
models. For the best model, Δi = Δmin = 0.  Then, we can calculate the model probabilities ωi 
(Burnham, Anderson et al. 2002) 
 ω𝑖𝑖 = exp �−
Δ𝑖𝑖
2
� /∑ exp �−Δ𝑟𝑟
2
�𝑚𝑚𝑖𝑖=1   (25) 
The sum of the ω among the candidate models is 1. ωi represents the weight of evidence 
when the ith model is the best model that minimizes the information loss in the set of m models. 
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It is also called Akaike weight. For example, if one model’s ω is 0.3, it means that this model 
has 30% probability to be the best model in the set. Although we used AICc to screen the best 
model, the results we get are not necessarily accurate. The AICc weight can help us judge the 
possibility of other best models for analysis. 
4.9 Model selection results 
4.9.1 Activin regulated transcriptional responses are explained by 
different kinetic models 
 Model selection results for 10 models ranked by AICc weight are shown below (Figure 30) 
(Appendix A, B). For most target genes, the fitting results for mRNA half-life data are very 







Figure 30 | Model selection results. A. Hierarchically-clustered heatmap for each target gene 
showing the AICc weight of fitted models (colour bar) and unfitted models (grey). B. 
Percentage of the best model based on AICc weight.  
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As it shown in Figure 30, model3 can fit 37 of 70 (52.86%) target genes that have Smad2 
binding information. This result indicates that Smad2 plays a role in promoting mRNA 
production rate of these genes. In addition, model4 is selected as the best model for only 1 gene 
(Id3), indicating that Smad2 rarely repress mRNA production rate of the target genes. 
Furthermore, both model5 and model6 are selected as the best model for 5 genes, suggesting 
that Smad2 might regulate the expression of these genes through promoting or inhibiting their 
mRNA degradation rates. The models assuming mRNA production rate is nonlinear to Pol II 
activity can only account for 10 of these 70 genes that have Smad2 binding density. 
Interestingly, although Smad2 binds to the promoter of some genes, it doesn’t contribute to the 
best models (model1 and model2) that fit these genes. This result suggest that Smad2 binding 
does not always have function on the regulation of the target gene. 
We next analyzed the biological function of the genes that are best explained by model 3 
(i.e.: Smad2 promoted transcription). The GO term enrichment analysis for biological process 
(BP) (Figure 31) and molecular function (MF) (Figure 32) was applied to identify the biological 
characteristics of the genes. Genes with Smad2 promoted transcription mainly involved in 
biological development processes, such as genes associated with metanephros, kidney, and 
midbrain-hindbrain boundary development or cellular developmental processes, like cell fate 
specification, cell migration or cell differentiation. For example, the model3 genes include 
members of the fibroblast growth factors (FGF) family; e.g., Fgf8 and Fgf15, which is critical 
in regulating cell proliferation, migration and differentiation during embryonic development 
(Ornitz and Itoh 2001). The FGF pathway reportedly cooperates with Activin/Nodal pathway 
to maintain pluripotency of hESCs (Vallier, Alexander et al. 2005). The molecular functions 
of model3 genes included Wnt-protein binding, growth factor receptor binding and RNA 
polymerase II proximal promoter sequence-specific DNA binding. All of the results showed 
that genes with Smad2 promoted transcription, which exhibited variable distribution of 




Figure 31 | Gene Ontology enrichment analysis of biological processes for fitted target 
genes among three categories.  The data was analyzed by GO Enrichment Analysis (Mi, 




Figure 32 | Gene Ontology enrichment analysis of molecular functions for fitted target 
genes among two categories. The data was analyzed by GO Enrichment Analysis (Mi, 
Muruganujan et al. 2019). 
4.9.2 Linear and non-linear Pol II regulated genes 
The kinetic models can be classified into two groups: (i) linear Pol II model, in which mRNA 
production rate is linear to the activity of Pol II (model 1, 3-6) and (ii) nonlinear Pol II model, 
in which mRNA production rate is nonlinear to the activity of Pol II (model 2, 7-10). As shown 




Figure 33 | Percentage of the linear and non-linear Pol II models that best explain genes with 
Smad2 binding activity.  
4.9.3 Smad2 is not required for the regulation of some genes 
 There are 5 genes (Cyr61, Grsf1, Id1, Kcnj3, Nodal), whose expression data are not best 
fitted by the models that are related to Smad2 activity. These genes can be regarded as Smad2-
independent genes. Among these genes, Id1 is a famous TGF-β superfamily target genes. ID 
genes are mediated by Smads and down-regulated in epithelial cells (Kang, Chen et al. 2003). 
Our modeling analysis result is consistent with previous studies. For example,  it has been 
reported that Smad3, but not Smad2, mediates early expression of Id1 by TGF-β1 (Liang, 
Brunicardi et al. 2009). Expression of Id1 was regulated differently as compared to Id2 and Id3 
in healing skin wounds, during which Activin is highly expressed (Hubner, Hu et al. 1996, 
Rotzer, Krampert et al. 2006). In the P19 cell line, it also seems that the Id1 and Id2 are 
regulated differently by Nodal/Activin (Coda, Gaarenstroom et al. 2017). In addition, Cyr61, 
also known as cysteine-rich angiogenic inducer 61, is a member of the CCN family.  After the 
specific knockdown of Smad2 and Smad3 by RNA interference, the TGF-β1-induced secreted 







Identifying the features for predicting 
the types of gene expression induced by 
Activin 
In Chapter 4, we presented ODE models to understand the temporal dynamics of mRNA 
transcription and degradation. As Activin induced gene expressions can be classified into 
different clusters depending on their dynamics. We use logistic regression model to identify 
which kind of gene features (e.g.: epigenetic modifications, Pol II binding, Smad2 binding etc.) 
can help us to predict the types of mRNA transcription dynamics. We find the most important 
feature associated with gene expression labels was Pol II occupancy and there is no correlation 
between mRNA half-life and transcription profile. 
5.1 Classification of Activin induced gene expression 
dynamics 
 As Activin triggers different temporal patterns of gene expression, we classified Activin 
regulated genes into two groups according to the FC of mRNA at 8h:   
1. Active genes. This kind of gene has been up-regulated by signaling. The genes were 
selected into this cluster if RNA 8h FC ≥ 1. 
2. Repressed genes. This kind of gene has been down-regulated by signaling. The genes 
were selected into this cluster if RNA 8h FC < 1. 
 
 73 
We first focused on 70 genes that have Smad2 binding peaks (Figure 34).  
 
Figure 34 | Gene clusters. A. The 70 target genes with Smad2 binding were classified into the 
two clusters defined above. Active genes = 54; repressed genes = 16. B. Log2FC relative to 
SB-431542 at each time point plotted for three clusters. 
5.2 Epigenetic features selection 
Now based on the sequencing data, we obtained mRNA half-life, Pol II Ser2p, Smad2, 
H3K9ac and H3K27ac binding profiles for each gene (Table 8). In order to understand which 
features might determine the classification of the gene into one of the three distinct kinetic 
clusters, we evaluated these features for predicting the type of gene expression pattern using 







Table 8 | Gene features used for logistic regression modeling. 
Gene features      Data 
General  transcription 
regulators 
RNA Pol II Ser2p 1h RNA Pol II Ser2p 4h RNA Pol II Ser2p 8h 
Transcription factors Smad2 1h Smad2 8h  
Chromatin modifications 
H3K27ac 1h H3K27ac 4h H3K27ac 8h 
H3K9ac 1h H3K9ac 4h H3K9ac 8h 
Others Half-life time   
 
One feature or the combination of 2 features were systematically analyzed in this work. For 
the combination of two features, there may be significant associations between 2 features.  This 
problem is known as collinearity (Miles and Shevlin 2001). In this situation, it can be difficult 
to have reliable estimates of individual coefficients for variables (Neter, Wasserman et al. 1989, 
Kang 2013). To avoid this problem in logistic regression modeling analysis, we used variance 
inflation factors (VIF) to exam whether the presence of collinearity in the selected gene features 
or not. The VIF for an independent variable xi defined as 




where Ri2 is the R2 for a covariate xi regressed on the remaining covariates in the model. A rule 
of thumb is that a VIF more than 10 may indicate the presence of collinearity (Marquandt 1980). 
 The VIFs of gene features are shown in Figure 35. There is a striking correlation between 
the “H3K27ca FC 4h” and “H3K27ca FC 8h”. More than just H3K27ca, H3K9ac, and Pol II 
are also highly correlated at 4h and 8h time points. This indicates that histone acetylation status 
of the target genes may have already been in a steady state at 4h. Based on the VIF values, we 
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excluded the feature combination with VIF more than 10 - combination of “H3K27ca FC 4h” 
and “H3K27ca FC 8h”. In total, we evaluated 12 single-feature and 65 two-feature 
combinations. 
 
Figure 35 | Variance inflation factors (VIF) for features.  The plot shows the log10 VIF 
based on Spearman’s rank correlation coefficient.  
5.3 Logistic regression methods 
 For each feature or combination of 2 features, we use a logistic regression function to predict 
the type of gene expression. Logistic regression is a process of modeling the probability of a 
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certain class or event existing given a set of independent variables. Here we applied binary 
logistic regression, which was developed primarily by Cox and Walker and Duncan to predict 
two categories (Cox 1958, Walker and Duncan 1967). The training algorithm is described in 
Figure 36 and elaborated as below:  
 
Figure 36 | Logistic function. In the logistic model, hθ (x) is interpreted as the probability of 
the dependent variable y = 1 than y = 0. 
1. We started by considering the group of “repressed genes” as a binary value depending 
on whether it is classified into the type of expression kinetics. For convenience, we 
encode 1 or 0. For example, we defined  
𝑦𝑦𝑖𝑖 = �
1, 𝐺𝐺𝑓𝑓 𝑡𝑡ℎ𝑒𝑒 𝐺𝐺𝛾𝛾ℎ 𝑙𝑙𝑒𝑒𝐺𝐺𝑒𝑒 𝐺𝐺𝐺𝐺 𝑐𝑐𝑙𝑙𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝑓𝑓𝐺𝐺𝑒𝑒𝑜𝑜 𝐺𝐺𝐺𝐺 “𝑠𝑠𝑒𝑒𝑝𝑝𝑠𝑠𝑒𝑒𝐺𝐺𝐺𝐺𝑒𝑒𝑜𝑜 𝑙𝑙𝑒𝑒𝐺𝐺𝑒𝑒𝐺𝐺”  
0, 𝑙𝑙𝑡𝑡ℎ𝑒𝑒𝑠𝑠𝑤𝑤𝐺𝐺𝐺𝐺𝑒𝑒.
 
2. For a parameter θ, the logistic regression estimates a probability that y = 1 by applying 
the logistic function: 
 ℎ𝜃𝜃(𝑥𝑥) =  
1
1 +  𝑒𝑒−𝜃𝜃𝑇𝑇𝑥𝑥
 (27) 
so hθ (x) presents the probability of the outcome being 1 and 1 - hθ (x) presents the 
probability of the outcome being 0.  
3. Given a vector of binary class label y = (y1, y2,…, ym), parameter θ can be estimated by 








+ (1 − 𝑦𝑦𝑖𝑖)𝑙𝑙𝑙𝑙𝑙𝑙 (1 −  ℎ𝜃𝜃(𝑥𝑥𝑖𝑖)) 
(28) 
where m is the sample abundance.  
4. The maximum likelihood estimator of θ is applied to make class predictions on test data 
to measure model performance.  
Here, we used glmfit function (MATLAB Statistics Toolbox, Mathworks, Natick, MA, USA) 
for fitting logistic models on the train data. We first separated target genes into three groups 
randomly. To identify the features that predict the types of target gene expression kinetics and 
assess the generalization power of features, the logistic regression classifier was trained on 
each feature or combination of 2 features in a round-robin fashion for cross-validation. Training 
on two groups and testing on the remaining group, we repeated this procedure three times in a 
round-robin and evaluated logistic regression classifier performance by following methods 
(Buggenthin, Buettner et al. 2017) (Figure 37). 
 
Figure 37 | Schematic of round-robin training and testing.  The data was separated into 
three groups. At each round, two groups would be treated as train data and the third group 
would be the test data. This procedure will be repeated for three times in a round-robin.  
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5.4 Quantifying the quality of predictions 
 . In order to compare the logistic regression models based on different features, we used 
Cohen's kappa coefficient to quantify the quality of model predictions. The Cohen’s kappa is 
a statistical coefficient that shows the degree of accuracy and reliability in a statistical 
classification. It measures the degree of agreement among raters (Cohen 1960).  





+ a b R1 
_ c d R2 
Total C1 C2 N 
 
Suppose we have a dataset that contains only two categories. Each data is evaluated by two 
methods and each method either clusters “+” or “-” to the data. Suppose the count data is as 
Table 9, where both A and B are methods, a and d count the number of agreements, along with 
b and c count the number of disagreements. R1 and R2 show the number of two categories 
clustered by A. C1 and C2 show the number of two categories clustered by B. N is the total 
number of the dataset. 
The definition of Cohen's kappa is: 
 
𝐴𝐴𝑙𝑙ℎ𝑒𝑒𝐺𝐺′𝐺𝐺 𝑘𝑘𝐺𝐺𝑝𝑝𝑝𝑝𝐺𝐺 =  
 𝑝𝑝0 − 𝑝𝑝𝑒𝑒
1 −  𝑝𝑝𝑒𝑒
=
𝑁𝑁(𝐺𝐺 + 𝑜𝑜) − (𝑅𝑅1𝐴𝐴1 + 𝑅𝑅2𝐴𝐴2)
𝑁𝑁2 − (𝑅𝑅1𝐴𝐴1 + 𝑅𝑅2𝐴𝐴2)
 (29) 
Where p0 is the ratio of total observed agreement among raters to all observations, and pe is the 
agreement that is expected to occur by chance. The Cohen's kappa value can range from -1.00 





Table 10 | Interpretation of  the Kappa value according to the reference (Landis and Koch 
1977). 
Kappa Value Strength of agreement 





0.81–1.00 Almost perfect 
 
However, Cohen's kappa has some limitations (Cicchetti and Feinstein 1990). If there is a 
huge discrepancy between the positive agreement rate (a / N) and the negative agreement rate 
(d / N), the calculated Cohen's kappa value will be low, as well as the true degree of the 
agreement will be underestimated. For example, if a = 98, b = c = 1 and d = 0, though the 
accuracy equals 0.98, the Cohen's kappa will be -0.01 for this result. In addition, when a, d and 
the sum of b and c are the same, a higher difference between b and c of the higher Cohen's 
kappa will be produced. 
Due to the limitations of Cohen's kappa, we also use other forms of measurement to evaluate 
the classification results. Because transient induced genes make up more than half of the target 
genes, the quantity of “accuracy” seems unsuitable for this uneven class distribution. In order 
to measure the accuracy of the test, we employed the F1 score that is derived from precision 
and recall for classification  results evaluation (Sasaki 2007).  
To calculate the F1 score, the precision and the recall of the results are first derived based 




Table 11 | Four outcomes of a classification result (a 2×2 contingency table or confusion 
matrix) 
                    True condition 
Predicted condition 
Positive Negative 
Positive True positive (TP) False positive (FP) 
Negative False negative (FP) True negative (TN) 
 
Precision is the ratio of the correctly predicted positive observations to all of the predicted 
positive observations. 
 𝑃𝑃𝑠𝑠𝑒𝑒𝑐𝑐𝐺𝐺𝐺𝐺𝐺𝐺𝑙𝑙𝐺𝐺 =  
𝑇𝑇𝑃𝑃
(𝑇𝑇𝑃𝑃 +  𝑉𝑉𝑃𝑃)
 (30) 
Recall is the ratio of the correctly predicted positive observations to the total observations in 
the positive class. 




The F1 score is defined as the harmonic mean (average) of the precision and recall. The F1 
score can range from 0 to 1, with 1 for a best result 1 and 0 for a worst one. 
 
𝑉𝑉1 𝐺𝐺𝑐𝑐𝑙𝑙𝑠𝑠𝑒𝑒 = (
𝑅𝑅𝑒𝑒𝑐𝑐𝐺𝐺𝑙𝑙𝑙𝑙−1 +  𝑃𝑃𝑠𝑠𝑒𝑒𝑐𝑐𝐺𝐺𝐺𝐺𝐺𝐺𝑙𝑙𝐺𝐺−1
2
)−1 = 2 ∗
𝑅𝑅𝑒𝑒𝑐𝑐𝐺𝐺𝑙𝑙𝑙𝑙 ∗  𝑃𝑃𝑠𝑠𝑒𝑒𝑐𝑐𝐺𝐺𝐺𝐺𝐺𝐺𝑙𝑙𝐺𝐺
𝑅𝑅𝑒𝑒𝑐𝑐𝐺𝐺𝑙𝑙𝑙𝑙 +  𝑃𝑃𝑠𝑠𝑒𝑒𝑐𝑐𝐺𝐺𝐺𝐺𝐺𝐺𝑙𝑙𝐺𝐺
 (32) 
The macro-averaged F1 score calculated the performance metrics for each cluster (C), and 









For each feature or combination of 2 features, we reported the macro-averaged F1 score of two 
classes: active genes and repressed genes. 
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5.5 Pol II binding features associated with target gene 
expression patterns 
The F1 score and Cohen's kappa for the best five features or combinations are shown below 
(Table 12) (Appendix C). If only one feature is used, the best three features for predicting gene 
expression patterns are the same: “Pol II FC 4h”, “Pol II FC 8h” and “H3K27ac FC 8h”, no 
matter whether F1 score or Cohen’s kappa is used for evaluation. “Pol II FC 4h” received a 
slightly higher F1 score and Cohen's kappa. While the results of other features like chromatin, 
modification or transcription factors are quite different from Pol II. For two features, the 
combination of “Pol II FC 4h” and “H3K9ac FC 1h showed a similar F1 score and Cohen's 
kappa as other combinations of 2 features. No combinations of 2 features had outstanding better 
performance compared to the model with “Pol II FC 4h” feature. Therefore, the feature of “Pol 
II FC 4h” is the best marker to predict the type of gene expression kinetics induced by Activin. 
The confusion matrices of “Pol II FC 4h” for the three test data are shown in Figure 38. It is 
worth noting that the model with “mRNA half-life time” feature alone has the worst 
performance on predicting the type of target gene expression kinetics, which show similar 
Cohen's kappa score as a random classification method (Appendix D, -0.025). This suggests 
that mRNA degradation of these genes were not substantially changed by Activin stimulation. 
Table 12 | Feature importance for distinguishing clusters.  
Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
Pol II FC 4h 0.875 0.750 
 
Pol II FC 4h and H3K9ac FC 1h 0.882 0.764 
Pol II FC 8h 0.814 0.629 
 
Pol II FC 4h and Pol II FC 8h 0.878 0.757 
H3K27ac FC 8h 0.750 0.516 
 
Pol II FC 4h and Half-life time 0.878 0.755 
H3K9ac FC 4h 0.713 0.432  Pol II FC 4h and SMAD2 FC 1h 0.875 0.750 







Figure 38 | The confusion matrix of round-robin of “Pol II FC 4h” feature. 
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5.6 Robustness of gene features for predicting the 
subcategories of active gene expression with different 
classification standards 
The active genes are further classified into two subcategories. One is “induced sustained”. 
This type of gene has been up-regulated and persists over time. The other is “transient induced”. 
This type of gene has been up-regulated and slowly rises after prolonged signaling. For 
classification between “induced sustained” and “transient induced”, a gene was designated as 
“induced sustained” if its RNA 8h FC/RNA 1h FC was more than the cutoff. To test how robust 
gene features can predict the types of target gene expression, we classified the target genes by 
trying three different cutoff of RNA 8h FC/RNA 1h FC (1.5, 2 and 3) for distinguishing 
“induced sustained” and “transient induced” genes. The different rules lead to different 
numbers of genes for two groups (Figure 39). 
 
Figure 39 | Subcategories in active genes. Left: Active genes were clustered using RNA 8h 
FC/ RNA 1h FC filter of 1.5. Induced sustained genes = 37; transient induced genes = 17. 
Middle: Active genes were clustered using RNA 8h FC/ RNA 1h FC filter of 2. Induced 
sustained genes = 29; transient induced genes = 25. Right:  Active genes were clustered using 




Differently from the analysis by Coda et al. (Coda, Gaarenstroom et al. 2017), the “delayed 
genes” were not considered because only a few genes would fall into this group and their 
expression pattern may be categorized into “induced sustained” or “transient induced” group. 
We next evaluated the performance of logistic regression models with different gene features 
again (Table 13).  Compared with the results of three rules, the top five models with a single 
feature are similar and the best single feature for predicting the types of active gene expression 
kinetics is “Pol II FC 8h”.  A combination of this feature with Smad2 binding or H3K9ac 
modification data can slightly increase F1 and/or Kappa scores when using RNA 8h FC/ RNA 
1h FC filter of 1.5 or 3. The combinations of Smad2 binding and H3K27ac modification data 
showed a similar F1 score and Cohen's kappa as other combinations of 2 features when using 
















Table 13 | Feature importance for distinguishing active genes.  
FC 
filter 
Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
1.5 
Pol II FC 8h 0.693 0.415  Pol II FC 8h and Smad2 FC 8h 0.732 0.503 
SMAD2 FC 8h 0.676 0.365  Pol II FC 8h and Smad2 FC 1h 0.726 0.418 
H3K27ac FC 8h 0.560 0.219  H3K27ac FC 8h and H3K9ac FC 4h 0.713 0.271 
H3K9ac FC 4h 0.546 0.159  Smad2 FC 8h and H3K9ac FC 4h 0.702 0.372 
Pol II FC 4h 0.532 0.156  Half-life time and Smad2 FC 8h 0.702 0.294 
2 
Pol II FC 8h 0.699 0.415  Smad2 FC 8h and H3K27ac FC 4h 0.766 0.536 
H3K27ac FC 4h 0.684 0.387  Smad2 FC 8h and H3K27ac FC 8h 0.749 0.502 
SMAD2 FC 8h 0.678 0.372  Pol II FC 8h and Smad2 FC 8h 0.748 0.503 
H3K27ac FC 8h 0.656 0.318  Smad2 FC 1h and H3K27ac FC 8h 0.735 0.474 
Pol II FC 4h 0.620 0.282  Pol II FC 1h and Pol II FC 8h 0.734 0.482 
3 
Pol II FC 8h 0.796 0.598  Pol II FC 8h and H3K9ac FC 4h 0.830 0.671 
Pol II FC 4h 0.714 0.436  Pol II FC 8h and H3K9ac FC 8h 0.830 0.671 
H3K27ac FC 8h 0.703 0.450  Pol II FC 1h and Pol II FC 8h 0.811 0.625 
SMAD2 FC 8h 0.695 0.398  Pol II FC 8h and H3K27ac FC 1h 0.791 0.588 




The rules for the classification of target genes (Figure 39) is not objective as the cutoffs are 
set arbitrary. Instead of setting cutoff, we applied k-means to create subcategories for active 
genes (Forgy 1965, MacQueen 1967, Hartigan and Wong 1979, Lloyd 1982) (Figure 40). 
 
Figure 40 | Subcategories in active genes by applying k-means. Active genes were clustered 
using k-means. Induced sustained genes = 9; transient induced genes = 45. 
For subcategories generated by k-means, the “H3K27ac FC 8h” is the best single feature to 
predict the types of active gene expression kinetics, followed by “Pol II FC 8h” (Table 14). 
Combinations of “H3K27ac FC 8h” with H3K9ac modification data can slightly increase F1 
and Kappa scores. According to all of the above results, it seems that good predictions to 
distinguish active genes can be achieved at different cutoffs or with k-means clustering 








Table 14 | Feature importance for distinguishing active genes by applying k-means.  
Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
H3K27ac FC 8h 0.884 0.775  H3K27ac FC 8h and  H3K9ac FC 1h 0.884 0.775 
Pol II FC 8h 0.772 0.551  H3K27ac FC 8h and  H3K9ac FC 4h 0.884 0.775 
H3K27ac FC 4h 0.669 0.354  H3K27ac FC 8h and  H3K9ac FC 8h 0.865 0.736 
Pol II FC 4h 0.582 0.182  H3K27ac FC 1h and H3K27ac FC 8h 0.862 0.726 
H3K27ac FC 1h 0.573 0.186  Pol II FC 4h and H3K27ac FC 8h 0.860 0.726 
 
We also applied method for predicting active and repressed genes to analyze all the 
differentially-regulated genes by Activin without Smad2 binding. However, none of the 
features is good for predicting the type of gene expression kinetics (Table 15).  
Table 15 | Feature importance for clusters of differentially-regulated genes.  
Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
Half-life time 0.628 0.290  Pol II FC 4h and Half-life time 0.639 0.306 
H3K9ac FC 8h 0.506 0.080  Pol II FC 1h and Half-life time 0.628 0.290 
H3K9ac FC 4h 0.492 0.060  Pol II FC 8h and Half-life time 0.628 0.290 
Pol II FC 4h 0.475 0.027  Half-life time and H3K27ac FC 1h 0.628 0.290 
Pol II FC 1h 0.450 0.000  Half-life time and H3K9ac FC 1h 0.628 0.290 
 
The highest Cohen's kappa is about 0.31 for the combination of 2 features of “Pol II FC 4h” 
and “Half-life time”, which indicate that it is not stronger than expected result from random 
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classification. We noticed that the majority of 128 differentially-regulated genes are classified 
into the group of “active” genes (82.03%) (Figure 41).  
 
Figure 41 | Number and percentage of gene clusters for differentially-regulated genes. 
The extremely imbalanced gene cluster data might affect the performance of classification 
predictions made from logistic regression models. To address this issue, we tried an over-
sampling approach to deal with the extremely imbalanced data. Random oversampling simply 
randomly choose the minority class of the training data and copy them until the two classes 
had the same number of data (Ling and Li 1998).  However, random oversampling had almost 
no improvement in the results for predicting the types of target genes: the best F1 score 
increased from 0.64 to 0.68, as well as the Cohen's kappa increased from 0.31 to 0.37 at the 
same time (Table 16). 
Table 16 | Feature importance for clusters of differentially-regulated genes 
(oversampling).  
Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
H3K9ac FC 8h 0.663 0.342  Half-life time and H3K9ac FC 8h 0.682 0.373 
H3K27ac FC 4h 0.612 0.290  Pol II FC 1h and H3K9ac FC 8h 0.676 0.365 
H3K9ac FC 4h 0.586 0.197  Pol II FC 4h and H3K9ac FC 8h 0.670 0.355 
H3K27ac FC 8h 0.583 0.239  Half-life time and H3K27ac FC 8h 0.666 0.350 




Taken together, our results indicate that the dynamics of target genes without Smad2 binding 
cannot be well predicted from histone modifications and or pol II binding features. As TGF-β 
superfamily signals often crosstalk to other signaling pathways and recruit the binding of other 
transcriptional factors. Therefore, the prediction of these genes maybe improved by including 






Conclusion & Discussion 
 Cell signaling networks are complex and dynamic systems that ensure cells sense and 
respond to their environment. The TGF-β is one of the most important signaling events. It 
regulates many different cellular processes such as cell proliferation, migration, and death (Shi 
and Massague 2003). The Nodal/Activin is a member of the TGF-β superfamily, which is 
involved in many cellular processes. Abnormal activity of the Nodal/Activin has been 
connected to human diseases such as cancers (Pauklin and Vallier 2015).  
In this study, we used mathematical modeling approaches to study transcriptional responses 
to Activin signal. As a result, the mathematical models helped us to understand how Activin 
signal induces different kinetic profiles of gene expression. The results suggest that Activin 
regulates target genes through different mechanisms. In addition, using logistic regression 
models, we found that the kinetic patterns of the genes bound with Smad2 can be well predicted 
by their Pol II binding profiles.  
6.1 Smad2 activities linked to TGF-β induced transcription 
regulation 
 It is known that Smads play important roles in regulating downstream responses of TGF-β 
signaling. Smads are thought to interact with a number of co-activators and co-repressors to 
induce chromatin remodeling. Ross et al. show that Smad2-mediated transcription requires 
specific histone modifications and chromatin remodeling (Ross, Cheung et al. 2006). The 
repression of Runx2 function by Smad3/HDAC complex depended on the regulation of the 
histone acetylation levels guided by Smad3 binding specificity (Kang, Alliston et al. 2005). 
These findings suggest that Smads regulate gene responses by regulating Pol II activities. 
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However, our model selection results indicate that Smad2 regulates target genes not only 
through the recruitment of Pol II transcription machinery, but also through participation in the 
degradation for some genes. For example, the top model of Dusp4 and Enpp2 is model5, which 
indicates that Smad2 binding level promotes mRNA degradation rates. Through the model 
selection, we analyzed the regulation of each gene. The results produced by some of these 
genes are consistent with previous literature or experiments. 
6.2 Signaling crosstalk between Activin and other signaling 
pathways 
 TGF-β super family signal talks with other pathways at many development stages. The 
interaction between TGF- β and Wnt pathway has been known for a long time (Attisano and 
Labbe 2004). Our results show that Wnt3 and Wnt11, which are best explained by model3 and 
model7, are regulated by Activin/Nodal signaling via Smad2 (Figure 30). In additional, Msx2 
genes that are induced by Wnt and BMP pathways, play a crucial role in neural development 
(Willert, Epping et al. 2002). These genes also show strong FC after Activin/Nodal stimulation, 
which indicate that other pathway regulators could contribute to the control of target gene 
expression. 
6.3 Correlation between gene features and the dynamics of 
transcription responses 
Degradation is an important step for mRNA stability regulation. Previous studies have 
suggested that mRNA degradation plays an important role in the regulation of gene expression 
by phosphatidylinositol 3-kinase signaling (Graham, Hendershott et al. 2010). In some of our 
kinetic models, we assume that mRNA degradation rate is not changed after Activin 
stimulation. It may be unrealistic, but the ‘constant degradation’ model reportedly can fit the 
majority of genes well (Rabani, Levin et al. 2011).  By comparing different models, we found 
that Smad2 is possibly involved in regulating mRNA degradation of a few target genes. 
However, when we look at 70 genes that are bound with Smad2 after Activin stimulation, we 
found the mRNA half-life time is a poor feature for predicting the dynamics of mRNA 
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transcription. In contrast, the binding profile of Pol II Ser2P at 4h or 8h is a very good feature 
for predicting the types of transcription dynamics for genes with Smad2 binding profile. It is 
interesting that this feature is not good for the prediction of other genes that are not bound with 
Smad2. This indicate that other transcriptional factors (co-activator or co-repressor) might play 
a more important role in shaping the dynamics of these genes. Future works are needed to 
elucidate the mechanism for controlling the transcriptional dynamics of these genes.  
6.4 The limitations of this work 
In this work, we aimed to understand the regulation of transcription dynamics for all Activin-
regulated genes (in total 198 genes). However, we found that the kinetic models or logistic 
regression models could explain well only for the group of target genes that have Smad2 
binding activities. The insights from this study might be due to the following limitations.  
Limited samples in RNA-seq data 
 The RNA-seq data for gene expression are only available at 1h and 8h after Activin 
stimulation. Due to the limited samples, the change of some genes may not be detected. For 
example, the jun proto-oncogene (c-jun) has been reported to be decreased very rapidly after 
an initial rise (Mauviel, Chung et al. 1996) (Figure 42A). In our data set, the dynamics of c-jun 
is reduced due to lack of early sampling point. In contrast, the Pol II activity shows an increase 
at the beginning and then a decrease (Figure 42B). That may explain why our model could not 







Figure 42 | Expression of c-jun. A. A rough plot for the original data shown in the paper of 
Mauviel 1996. B. Transcription dynamic and Pol II activity of c-jun via sequencing. 
The lack of Smad3 activities 
Nodal/Activin signaling pathway is mediated specially by Smad2/3 and Smad4. In this study, 
as we only have the ChIP-seq data for Smad2, Smad3 binding activities for the target genes 
were not considered. Although the western blot data we used did not detect strong Smad3 signal, 
the level of phosphor-Smad3 proteins in P19 cells has been reported to have increased after 
treatment with Activin (Mazerbourg, Klein et al. 2004). Due to the lack of available Smad3 
binding data, Smad3-depedent genes may not be well predicted by the models present in this 
study.  
The limitations of annotation 
Most of the recent studies have demonstrated that 1-20% of SMAD2 binding sites are 
involved in the regulation of nearby gene expression (Morikawa, Koinuma et al. 2013). The 
level of mature mRNA is regulated by a variety of processes, such as splicing and degradation.  
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Previous studies has indicated that Smads binding sites can be more than 50 kb away from the 
TSS of target genes (Landry, Bonadies et al. 2009, Morikawa, Koinuma et al. 2011, Trompouki, 
Bowman et al. 2011). Although we assigned Smad2 binding sites to the nearest genes within 
100 kb, only 70 of the 198 differentially-regulated genes were annotated with Smad2 binding. 
In addition to the lack of data for Smad3 binding, Activin stimulation may induce certain TFs 
that are involved in a feedforward regulatory loop and cooperatively regulate gene expression, 
especially at late time points (Yan, Xiong et al. 2017). 
6.5 Future directions 
Future work might be able to address above-mentioned limitations. First, in order to 
accurately identify the target genes of Smad-binding sites, the chromatin architecture needs to 
be well characterized. Chromosome conformation capture approaches such as Chromosome 
conformation capture (3C), Chromosome conformation capture-on-chip (4C), Chromosome 
conformation capture carbon copy (5C) or HI-C, make it possible to analyze the spatial 
organization of chromatin in a cell. Application of these technologies will help to capture the 
Smads binding activities for target genes more accurately and completely. In addition, more 
time points can improve the resolution of transcriptional dynamics for the target genes. 
In order to identify the features for predicting the type of transcriptional dynamics, we could 
analyze more features such as other sequence-specific TFs, structural proteins, inactivation 
chromatin modifications and genomic elements etc. when such kind of datasets are available 




A. The AICc values of the models.  
The genes that are highlighted in red cannot be fitted into any of the models. The last column 






















4930447C04Rik 59.0 59.1 30.1 66.9 66.2 60.3 44.8 73.4 73.7 73.5 m3 
Ago1 -11.8 -23.9 -166.0 -3.8 -3.8 -114.0 -33.4 4.2 5.3 2.8 m3 
Amot 38.9 -69.6 -99.9 46.9 34.4 38.7 -62.8 54.9 56.1 55.5 m3 
Angpt1 6.9 11.0 -152.4 14.8 14.7 -13.7 -37.2 21.3 21.4 20.4 m3 
Asb4 -27.1 -34.8 -102.0 -19.2 -30.4 -29.2 -69.7 -12.6 -12.1 -12.2 m3 
B630005N14Rik 9.2 12.6 -82.2 17.1 17.2 -26.0 3.6 21.9 21.9 20.1 m3 
Bmpr2 -38.5 -100.5 -161.5 -30.5 -31.4 -126.6 -107.2 -17.6 -13.5 -16.9 m3 
Camk2n1 -3.2 -14.4 -22.5 4.8 4.8 -9.5 -25.1 13.8 15.5 13.9 m7 
Ccno 4.9 -6.5 -11.0 12.8 12.8 -3.3 0.2 20.7 22.3 20.8 m3 
Cnpy1 36.7 27.8 -57.0 44.6 44.5 13.4 -58.3 51.3 52.0 50.9 m7 
Cyr61 -81.0 -128.1 -73.1 -98.3 -93.8 -90.9 -119.8 -89.5 -84.2 -95.1 m2 
Dact1 -15.0 -12.0 -148.0 -7.0 -7.0 -92.5 -13.7 0.4 0.6 -2.6 m3 
Dhrs3 89.8 82.1 -90.6 97.7 96.9 84.6 -12.5 104.3 104.9 104.2 m3 
Dusp4 -112.1 -145.6 -104.2 -169.0 -174.6 -103.8 -136.1 -67.7 -61.7 -67.0 m5 
Dusp5 -122.6 -130.9 -124.2 -114.6 -114.3 -138.1 -135.1 -89.7 -84.7 -94.6 m6 
Enpp2 -71.2 -66.2 -63.2 -65.4 -103.2 -63.2 -56.9 -57.0 -56.9 -56.7 m5 
Eomes 136.8 49.2 -68.1 144.7 143.5 133.9 -18.6 151.7 152.8 75.5 m3 
























Fgf15 60.7 38.6 -66.6 68.7 68.7 28.9 -51.2 76.9 77.6 75.9 m3 
Fgf8 109.6 103.9 -40.7 117.5 116.8 108.4 43.5 124.1 124.5 124.0 m3 
Fzd10 10.3 5.5 -54.0 18.3 18.4 -48.4 -15.2 31.7 31.8 27.3 m3 
Gadd45g 24.5 24.0 -38.1 32.5 32.5 12.7 -22.1 33.3 33.4 32.7 m3 
Gata3 -40.1 -54.3 -94.7 -32.1 -32.1 -73.4 -14.5 -20.5 -20.4 -23.8 m3 
Gbx2 -54.9 -50.1 -47.0 -53.0 -54.5 -46.8 -40.8 -39.9 -40.8 -39.0 m1 
Gm20544 66.2 42.6 -59.7 74.2 74.6 47.6 -24.8 81.2 82.0 80.9 m3 
Gm26562 28.6 31.4 -18.3 36.6 35.5 19.0 -3.1 43.1 43.2 42.6 m3 
Gm26793 65.2 67.8 49.9 73.2 73.2 67.4 65.5 77.1 77.1 76.8 m3 
Grsf1 -60.3 -207.2 -196.1 -52.3 -105.1 -144.9 -130.0 -16.2 -10.1 -13.6 m2 
Gsc 198.1 196.1 54.4 206.0 205.8 203.0 73.3 212.4 212.7 205.0 m3 
Gt(ROSA)26Sor 41.2 42.9 -0.9 49.2 49.2 33.3 27.7 52.2 52.2 51.5 m3 
Has2 -23.0 -107.6 -166.1 -15.0 -15.4 -114.5 -112.8 -3.0 1.0 -2.8 m3 
Hes1 31.5 37.7 -36.7 39.5 39.5 -19.2 8.2 47.0 47.0 45.6 m3 
Hist1h1c -15.1 -21.9 -7.1 -24.5 -89.0 -7.0 -12.8 -0.8 0.6 0.5 m5 
Hs6st2 10.2 9.4 -185.7 18.2 16.3 -39.6 -24.2 24.7 25.1 23.8 m3 
Id1 -127.6 -123.1 -100.5 -119.6 -119.6 -121.2 -113.5 -72.7 -70.0 -71.8 m1 
Id2 -135.7 -157.6 -158.6 -127.8 -127.2 -163.5 -148.3 -78.8 -73.7 -82.4 m6 
Id3 -119.8 -121.3 -111.8 -160.1 -156.6 -111.4 -111.8 -59.3 -55.8 -61.2 m4 
Il17rd -6.5 -47.0 -152.4 1.5 1.1 -122.1 -84.4 17.0 21.4 17.0 m3 
Irgm1 17.8 -7.1 -150.7 25.7 24.8 -70.3 -51.5 32.8 34.2 32.2 m3 
Itgb8 24.2 -13.1 -60.4 32.2 32.0 -11.3 -25.7 39.5 41.1 39.1 m3 
Kcnj3 -34.8 -95.1 -96.0 -26.8 -32.1 -66.4 -48.3 -17.3 -14.6 -16.6 m3 
























Lefty1 283.2 126.1 135.0 291.2 291.1 249.2 100.2 144.3 147.1 105.7 m7 
Lefty2 283.1 204.7 88.8 291.1 290.8 290.2 75.5 214.1 214.1 152.2 m7 
Lgr4 -16.9 -67.2 -164.3 -9.0 -10.0 -151.4 -33.3 5.2 9.4 5.5 m3 
Msx2 -77.4 -76.0 -114.8 -69.4 -69.3 -117.0 -87.3 -64.5 -64.2 -80.8 m6 
Naa30 23.8 26.6 31.8 23.3 31.8 29.5 31.7 35.8 35.9 35.9 m4 
Nanog 56.6 34.1 -116.6 64.6 64.4 35.0 -64.3 71.6 72.5 71.4 m3 
Nodal 4.2 -68.5 -56.4 12.2 12.2 -68.3 -66.0 41.3 47.2 37.5 m2 
Pak3 -10.9 -29.4 -135.6 -3.0 -5.4 -69.7 -44.1 4.0 5.3 3.6 m3 
Pde4b 33.9 32.2 -129.6 41.9 41.6 -29.9 -10.2 48.4 49.0 47.3 m3 
Pitx2 51.3 -17.3 -29.5 59.3 56.9 -95.2 -35.1 83.4 88.1 12.5 m6 
Pkdcc 54.8 27.6 -117.3 62.8 62.5 11.6 -93.1 70.5 72.0 70.1 m3 
Plagl1 25.2 -0.5 -110.5 33.2 31.8 18.5 -78.2 40.1 40.9 40.4 m3 
Pmepa1 162.9 146.1 48.0 170.8 170.8 139.6 5.3 177.6 179.0 123.6 m7 
Prdm1 -25.5 -42.5 -134.5 -17.5 -17.7 -132.7 -30.7 -9.9 -8.2 -12.2 m3 
Sh3bgrl 29.2 33.4 20.6 37.2 37.2 33.4 33.8 42.7 42.7 42.5 m3 
Ski -22.8 -35.6 -174.8 -14.9 -14.9 -133.6 -28.1 -5.4 -3.1 -6.4 m3 
Snai1 -66.1 -64.1 -77.0 -58.1 -58.0 -82.8 -57.8 -54.1 -54.0 -54.6 m6 
Sp5 44.0 -4.1 -5.4 52.0 49.9 22.6 3.0 62.7 65.5 61.6 m3 
Steap2 -11.4 -40.6 -179.3 -3.4 -4.0 -49.1 -24.8 4.1 5.6 4.2 m3 
T 109.9 -7.6 -44.6 117.9 112.9 113.5 -36.2 125.4 126.4 120.8 m3 
Tdgf1 140.3 -8.7 -51.9 148.3 145.2 144.1 -36.6 155.4 156.1 37.3 m3 
Tdh -75.6 -110.5 -67.7 -147.3 -225.7 -67.6 -101.3 -60.4 -57.0 -57.0 m5 
Trh 4.1 -136.5 -165.7 12.0 -15.7 -30.9 -64.4 31.6 35.2 32.7 m3 
























Wnt11 41.5 20.0 -121.5 49.4 49.2 29.3 -46.3 56.7 57.7 57.0 m3 
Wnt3 90.2 74.3 -42.5 98.2 98.2 68.1 -56.3 105.9 106.9 104.8 m7 
Ypel2 -15.8 -33.2 -96.6 -7.9 -9.3 -57.0 -44.7 -0.9 0.4 -1.5 m3 





B. The AICc weights of the models.  
The genes that are highlighted in red cannot be fitted into any of the models. For the fitted 
genes, if the AICc weight of any Smad2 independent models (model1 and model 2) has a value 
greater than 0.05, this gene may not be Smad2 dependent. And these Smad2 independent genes 

























4930447C04Rik 0.000 0.000 0.999 0.000 0.000 0.000 0.001 0.000 0.000 0.000 - 
Ago1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Amot 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Angpt1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Asb4 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
B630005N14Rik 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Bmpr2 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Camk2n1 0.000 0.004 0.207 0.000 0.000 0.000 0.789 0.000 0.000 0.000 Y 
Ccno 0.000 0.094 0.884 0.000 0.000 0.019 0.003 0.000 0.000 0.000 - 
Cnpy1 0.000 0.000 0.343 0.000 0.000 0.000 0.657 0.000 0.000 0.000 Y 
Cyr61 0.000 0.984 0.000 0.000 0.000 0.000 0.016 0.000 0.000 0.000 N 
Dact1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Dhrs3 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Dusp4 0.000 0.000 0.000 0.058 0.942 0.000 0.000 0.000 0.000 0.000 Y 
Dusp5 0.000 0.022 0.001 0.000 0.000 0.800 0.176 0.000 0.000 0.000 Y 
Enpp2 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 Y 
Eomes 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Epha2 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 Y 



























Fgf8 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Fzd10 0.000 0.000 0.942 0.000 0.000 0.058 0.000 0.000 0.000 0.000 Y 
Gadd45g 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 - 
Gata3 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Gbx2 0.437 0.039 0.008 0.163 0.343 0.007 0.000 0.000 0.000 0.000 - 
Gm20544 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Gm26562 0.000 0.000 0.999 0.000 0.000 0.000 0.001 0.000 0.000 0.000 - 
Gm26793 0.000 0.000 0.999 0.000 0.000 0.000 0.000 0.000 0.000 0.000 - 
Grsf1 0.000 0.996 0.004 0.000 0.000 0.000 0.000 0.000 0.000 0.000 N 
Gsc 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Gt(ROSA)26Sor 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 - 
Has2 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Hes1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Hist1h1c 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 Y 
Hs6st2 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Id1 0.846 0.087 0.000 0.016 0.016 0.035 0.001 0.000 0.000 0.000 N 
Id2 0.000 0.045 0.075 0.000 0.000 0.880 0.000 0.000 0.000 0.000 Y 
Id3 0.000 0.000 0.000 0.853 0.147 0.000 0.000 0.000 0.000 0.000 Y 
Il17rd 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Irgm1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Itgb8 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Kcnj3 0.000 0.398 0.602 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y/N 
Klf6 0.000 0.000 0.000 0.466 0.534 0.000 0.000 0.000 0.000 0.000 Y 



























Lefty2 0.000 0.000 0.001 0.000 0.000 0.000 0.999 0.000 0.000 0.000 Y 
Lgr4 0.000 0.000 0.998 0.000 0.000 0.002 0.000 0.000 0.000 0.000 Y 
Msx2 0.000 0.000 0.253 0.000 0.000 0.747 0.000 0.000 0.000 0.000 Y 
Naa30 0.377 0.093 0.007 0.485 0.007 0.021 0.007 0.001 0.001 0.001 - 
Nanog 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Nodal 0.000 0.459 0.001 0.000 0.000 0.409 0.131 0.000 0.000 0.000 Y/N 
Pak3 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Pde4b 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Pitx2 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 Y 
Pkdcc 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Plagl1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Pmepa1 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 Y 
Prdm1 0.000 0.000 0.707 0.000 0.000 0.293 0.000 0.000 0.000 0.000 Y 
Sh3bgrl 0.013 0.002 0.982 0.000 0.000 0.002 0.001 0.000 0.000 0.000 - 
Ski 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Snai1 0.000 0.000 0.050 0.000 0.000 0.950 0.000 0.000 0.000 0.000 Y 
Sp5 0.000 0.341 0.649 0.000 0.000 0.000 0.010 0.000 0.000 0.000 - 
Steap2 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
T 0.000 0.000 0.985 0.000 0.000 0.000 0.015 0.000 0.000 0.000 Y 
Tdgf1 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Tdh 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 Y 
Trh 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 
Ubr7 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 



























Wnt3 0.000 0.000 0.001 0.000 0.000 0.000 0.999 0.000 0.000 0.000 Y 
Ypel2 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Y 







C. Fitting of the best models to mRNA datasets 
According to the chi-square test, the unfitted data are shown with the red frame. The points 
show the GPR data. The 95% confidence intervals predicted from GPR model are shown as 
shaded regions. The simulation from the best model for each gene is shown in a black line.  
 





















D. The performance of logistic regression models with 
different features  
 The features were ranked by the F1 score. The top three F1 scores or Cohen's kappa values 
are highlighted in aquamarine. 
Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
Pol II FC 4h 0.875 0.750 
 
Pol II FC 4h and H3K9ac FC 1h 0.882 0.764 
Pol II FC 8h 0.814 0.629 
 
Pol II FC 4h and Pol II FC 8h 0.878 0.757 
H3K27ac FC 8h 0.750 0.516 
 
Pol II FC 4h and Half-life time 0.878 0.755 
H3K9ac FC 4h 0.713 0.432 
 
Pol II FC 4h and SMAD2 FC 1h 0.875 0.750 
H3K9ac FC 8h 0.713 0.432 
 
Pol II FC 4h and H3K27ac FC 4h 0.875 0.750 
SMAD2 FC 8h 0.703 0.418 
 
Pol II FC 4h and H3K27ac FC 8h 0.875 0.750 
H3K27ac FC 4h 0.692 0.393 
 
Pol II FC 4h and H3K9ac FC 4h 0.875 0.750 
H3K9ac FC 1h 0.588 0.220 
 
Pol II FC 4h and H3K27ac FC 1h 0.852 0.705 
H3K27ac FC 1h 0.522 0.111 
 
H3K27ac FC 1h and H3K9ac FC 8h 0.845 0.691 
Pol II FC 1h 0.466 0.019 
 
Pol II FC 4h and H3K9ac FC 8h 0.832 0.665 
SMAD2 FC 1h 0.435 0.000 
 
Pol II FC 1h and Pol II FC 4h 0.822 0.644 
Half-life time 0.431 -0.025 
 
Pol II FC 8h and H3K9ac FC 1h 0.804 0.613 
    
Pol II FC 1h and Pol II FC 8h 0.802 0.605 
    
H3K27ac FC 1h and H3K9ac FC 4h 0.795 0.592 
    
Pol II FC 8h and Half-life time 0.795 0.591 
    
H3K27ac FC 4h and H3K9ac FC 8h 0.789 0.583 
    
SMAD2 FC 8h and H3K27ac FC 4h 0.789 0.581 
    
SMAD2 FC 8h and H3K27ac FC 8h 0.789 0.581 
    
Pol II FC 4h and SMAD2 FC 8h 0.787 0.577 
    
H3K27ac FC 8h and H3K9ac FC 4h 0.772 0.550 
    
H3K27ac FC 8h and H3K9ac FC 8h 0.772 0.550 
    
Pol II FC 8h and SMAD2 FC 1h 0.768 0.542 
    
Pol II FC 8h and H3K9ac FC 4h 0.765 0.532 
    
Pol II FC 8h and H3K27ac FC 1h 0.764 0.530 
    
Pol II FC 8h and H3K27ac FC 4h 0.764 0.530 
    
Pol II FC 8h and H3K27ac FC 8h 0.764 0.530 
    
H3K27ac FC 4h and H3K9ac FC 4h 0.755 0.513 
    
Pol II FC 8h and SMAD2 FC 8h 0.751 0.506 
    
SMAD2 FC 8h and H3K9ac FC 8h 0.739 0.485 
    
SMAD2 FC 8h and H3K9ac FC 1h 0.733 0.477 
    
SMAD2 FC 8h and H3K27ac FC 1h 0.733 0.473 
    
Pol II FC 8h and H3K9ac FC 8h 0.732 0.469 
    
SMAD2 FC 8h and H3K9ac FC 4h 0.719 0.447 
    
Pol II FC 1h and H3K27ac FC 8h 0.717 0.451 
    
H3K9ac FC 4h and H3K9ac FC 8h 0.711 0.432 
    
H3K27ac FC 1h and H3K9ac FC 1h 0.710 0.423 
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Feature F1 score Kappa  Combination of 2 features F1 score Kappa 
    
SMAD2 FC 1h and SMAD2 FC 8h 0.706 0.415 
    
SMAD2 FC 1h and H3K27ac FC 8h 0.704 0.425 
    
H3K27ac FC 1h and H3K27ac FC 4h 0.704 0.425 
    
H3K9ac FC 1h and H3K9ac FC 4h 0.700 0.405 
    
H3K27ac FC 8h and H3K9ac FC 1h 0.697 0.412 
    
Half-life time and SMAD2 FC 8h 0.696 0.400 
    
SMAD2 FC 1h and H3K9ac FC 8h 0.695 0.397 
    
Pol II FC 1h and H3K27ac FC 4h 0.692 0.393 
    
SMAD2 FC 1h and H3K27ac FC 4h 0.692 0.393 
    
H3K27ac FC 1h and H3K27ac FC 8h 0.692 0.393 
    
Half-life time and H3K9ac FC 4h 0.686 0.382 
    
Half-life time and H3K9ac FC 8h 0.686 0.382 
    
SMAD2 FC 1h and H3K9ac FC 4h 0.686 0.382 
    
Pol II FC 1h and SMAD2 FC 8h 0.684 0.377 
    
Pol II FC 1h and H3K9ac FC 1h 0.683 0.385 
    
Half-life time and H3K27ac FC 8h 0.674 0.366 
    
Pol II FC 1h and H3K9ac FC 8h 0.666 0.338 
    
H3K27ac FC 4h and H3K9ac FC 1h 0.647 0.313 
    
Half-life time and H3K27ac FC 4h 0.646 0.302 
    
Pol II FC 1h and H3K9ac FC 4h 0.642 0.291 
    
H3K9ac FC 1h and H3K9ac FC 8h 0.636 0.278 
    
SMAD2 FC 1h and H3K27ac FC 1h 0.608 0.239 
    
SMAD2 FC 1h and H3K9ac FC 1h 0.591 0.196 
    
Half-life time and H3K9ac FC 1h 0.563 0.172 
    
Half-life time and H3K27ac FC 1h 0.541 0.097 
    
Pol II FC 1h and H3K27ac FC 1h 0.535 0.115 
    
Pol II FC 1h and SMAD2 FC 1h 0.484 0.016 
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